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ABSTRACT

Electrospinning technologies have been of great interest in recent years, due in
large part to developments in the field of Bioengineering, including the preparation of
novel polymers and advances in tissue engineering, specifically for therapeutic
applications. The electrospinning process is, in general, a very benign process that allows
the preparation, under mild conditions, of micro- and nano-scale fibers from fiberforming materials, as well as traditionally non-fiber forming materials. This process is of
specific interest to the biomedical community because it affords an opportunity to create
highly-tailored novel constructs with a multitude of possible uses. Some proposed uses
for these materials include tissue engineering scaffolds, wound dressings, drug delivery
devices, haemostatic aids and filters. The majority of the work to date, however, has
been focused on development of traditional non-bioabsorbable systems or bioabsorbable
systems exhibiting moderate to high tensile modulus and, hence, low compliance.
This dissertation overviews the first time production of viable biomedical fabric
with tailored properties. The results demonstrate that a series of novel polymers with a
broad range of physical/chemical properties can be processed with standard
electrospinning technology. Parameters were explored to modulate the initial properties
of electrospun fabrics. Fabrics produced from two novel families of polymers, identified
as PAX and AMP polymers, were found to be sterilizable and non-cytotoxic.
Bicomponent fibers were made to form a core/sheath morphology and parameters
affecting this morphology were explored. Methods were developed to include uniformly
dispersed bioactive insoluble micro-/nano-particulate in elecrospun fibers. The effect of

ii

drug structure on the corresponding release profile from absorbable electrospun fabrics is
discussed, along with a study to determine the zone of staphylococcus aureus inhibition
due to the release of triclosan from an absorbable electrospun fabric. Additionally, a
novel PEG-based family of polymers was electrospun and shown to display modulated
hydrophilicity and absorption profiles.
The overall objective of the research was to explore electrostatic spinning as a
means to forming novel absorbable and non-absorbable microfibrous biomedical
constructs with modulated physicochemical, mechanical and biological properties.
Results showed that microfibrous fabrics can be formed with open pore morphologies on
the order of cell dimensions, which may be advantageous for wound healing applications.
Added components, such as insoluble particles of phosphate glass for bone regeneration
or antimicrobial triclosan for wound repair/healing constructs, can increase the value of
electrospun fabrics and underscore the importance of their continued study.
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PREFACE

The purpose of this dissertation is to explore the preparation of electrospun fabrics
with biomedical significance from novel polymers. To this end, a test program was
devised to determine the efficacy of several methods of preparing and enhancing
electrospun fabrics and studying associated biomedically-relevant properties.
Specifically, electrospun fabrics were studied for their intended use in wound healing
devices. Initially, a literature review was performed to understand the history of wound
healing devices and electrospinning technologies. This review is discussed in Chapter 1.
With the completion of this review, specific research questions were developed to study
various methods of preparing and enhancing electrospun fabrics, as depicted in the
following figure, “Outline of Included Research.”
In Chapter 2, methodology to process tailor-made polymers is addressed. In
particular, electrospinning technology was developed to:
•

determine the feasibility of applying standard electrospinning technology, or
slightly modified versions thereof, to the preparation of absorbable and nonabsorbable polymers of biomedical significance

•

employ the devised electrospinning process in the preparation of microfibers from
candidate absorbable and non-absorbable polymers having a broad range of
physical/chemical properties

•

establish techniques for studying biomedically and clinically relevant microfiber
properties, and
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•

study the modulation of initial properties of fabrics by controlling the
electrospinning parameters and/or molecular dimensions

With methods for the preparation of electrospun fabrics established, studies were
developed to determine the ability to enhance these fabrics, as detailed in Chapters 3
through 6. The major research objective for studies detailed in each of these chapters,
respectively, are:
•

to apply the acquired knowledge of electrospinning single-component systems to
selected solutions of composite systems to produce composite microfibers.

•

to apply the acquired knowledge of electrospinning single-component systems to
multicomponent systems comprising solid micro-/nano-particles dispersed in
selected polymer solutions.

•

to study the effect of drug structure on its release from absorbable electrospun
fabrics, and

•

to electrospin model polyether esters and study the effects of the polyethylene
glycol (PEG) component on key microfiber properties.

This work is the result of many facets of research, much of which has been
presented at conferences over my tenure at Clemson University. Portions of these
materials have been presented at annual meetings of the Society for Biomaterials and the
Clemson University Tissue Engineering Workshop. These include: Effect of Drug
Structure on Release from Absorbable Electrospun Fibers (2007), Effect of Radiation and

xvii

Radiochemical Sterilization on the Polymer Properties of Absorbable Electrospun
Constructs (2007), and Electrospun Absorbable Microfiber Constructs I: Effect of
Electrospinning and Radiation on Polymer Properties (2004). This work has also
resulted in three patents and patent applications: Inorganic-Organic Hybrid Micro/Nanofibers (2005), Swellable Fiber- and Microfiber-Forming Polyether-Esters and
Applications Thereof (2005), and Hemostatic Microfibrous Constructs (2006).
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CHAPTER 1
INTRODUCTION

Current Status of Wound Healing Devices
The largest organ in the body is the skin, which acts as a defense system against
chemical, thermal and physical trauma. Skin is comprised of three distinct layers, the
epidermis, dermis, and the hypodermis, each of which provides specific functions in the
support and protection of the human body. The epidermis is a relatively thin layer
comprised of five sublayers and protects the body from water loss and physical damage.
This layer is composed primarily of keratinocytes which are formed in the inner-most
portion of the epidermis and migrate to the surface, which is comprised of dead cells that
are continually shed. The dermis, made of collagen fibers, elastin fibers, and
extracellular matrix, is responsible for giving the skin strength and elasticity. This layer
also contains blood and lymphatic vessels, nerve fibers, hair follicles, sebaceous and
sweat glands, and fibroblast cells. The hypodermis is a layer of adipose and connective
tissue containing major blood vessels, lymph vessels and nerves and serves to insulate the
body, absorb shocks to the skeletal system and help skin move more easily over
underlying structures.
As the outermost layer of the body and the first line of defense against attack, the
skin is subjected to occasional injury. Successful repair of any wound can be described
as containing four stages: hemostasis, inflammation, proliferation, and maturation. These
stages often overlap, but are all part of a successful wound healing process. Some
wounds, however, need assistance to pass through these steps in a timely fashion with the
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best possible outcome. The evolution of this assistance has occurred over thousands of
years, with the greatest level of advancement occurring in the last century.
Skin wounds are the most obvious type of injury, and as such there has been
interest in creating wound dressings for thousands of years. The Papyrus of Ebers, circa
1500 BC, describes the use of lint, animal grease and honey for wound treatment. The
advent of microbiology in the late 1800s, however, has led to the most significant
advances in the treatment and analysis of wounds and wound healing. One of the most
significant steps in wound care has come from the determination of proper wound-todressing selection and development of protocols for wound dressing care. The most
commonly used dressings include: alginates, foams, hydrocolloids, hydrogels, moist
saline gauze, and transparent films. Seventy-five percent of all applied wound dressings
are gauze, although this has been shown to provide the poorest wound-healing
environment. 1 This shows the effect of traditional (and often erroneous) views of wound
care and the need for new wound care products that are relatively inexpensive, readily
available, and easy to use.
Gauze has been used as a wound dressing for hundreds of years, and is still the
most widely-used dressing for many types of wounds.2 The familiarity of gauze
dressings is most likely the reason for their popularity, as there is much evidence to
support the use of other dressings instead of traditional gauze. Another leading reason
for the continued use of gauze is the perceived lower cost, although when all associated
costs have been studied this was shown to not be the case.1,3
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The family of gauze dressings include materials that are woven, non-woven,
impregnated with antibacterial materials, moistened with gels or saline, and many other
varieties.1 Dressings can be trimmed easily into shape, but typically require a secondary
dressing or tape to secure in place. Uses for gauze dressings include: mechanical
debridement, packing agent in dead space or tunnels, topical dressing for partial- and fullthickness wounds, exudative wounds, burns, and ulcers.1,4,5
Gauze dressings have many deficiencies that make other dressings better
candidates for use. A problem with these dressings is that they do not provide a moist
healing environment, and can cause the wound bed to dry out and can be considered a
hypertonic dressing, which can draw wound fluid, including blood and proteins, into the
dressing.1 This can cause the dressing to dry out, which can lead to painful dressing
changes or can rewound the placement site.1,4 They are not an effective bacterial barrier,
and provide even less protection when moistened, which has lead to higher infection rates
in wounds treated with gauze dressings compared to transparent films or hydrocolloids.1
Gauze requires frequent dressing changes and must be cared for properly to minimize
discomfort and injury upon removal, and proper technique is needed for placement in
chronic wounds or blood flow could be compromised.1,4 This requires nurses and
patients changing dressings to possess a higher skill level compared to newer products.
Virtually every new wound dressing is clinically tested against gauze. A reason
for this is that gauze is the most widely-used dressing and is falsely considered a “gold
standard” of care. Additionally, almost every new dressing can be shown to yield
significant improvement over traditional gauze, meaning comparisons between traditional
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and new products will generally favor the new product. Despite the amount of literature
reporting more-effective wound dressing products, gauze is still the most widely used. In
time, there will be one or more products that gain acceptance as the new standard of care.
In addition to fulfilling aspects of a successful wound dressing, the product(s) will need
to be easy to handle and adaptable to different clinical situations.
Alginates, or calcium alginates, are a class of wound dressing derived from
seaweed that are sold under tradenames such as: AlgiDERM®, Comfeel® Seasorb,
Maxorb®, NU-DERM™ Alginate, Sorbsan™, Tegaderm™ HI and HG Alginate, to name a
few. This class of wound management product is indicated for partial and full thickness
wounds with moderate to heavy drainage, post-operative wounds with minor bleeding,
and in wounds containing tunnels or cavities. Alginates form a gel upon contact with
exuding fluid; this yields a product that is highly absorbent and is removed easily with
little to no pain. Alginate dressings are an improvement over previous dressing materials
because they maintain a moist healing environment, are biodegradable, and can facility
autolysis. The high absorbency, however, makes their use contraindicated for dry wound
beds and 3rd degree burns, and the material can be malodorous on dressing change.
Additionally, the material’s “gel” nature can require a secondary dressing for securing the
dressing in the wound bed.1
The use of alginates is based on their improved ability to heal wounds compared
to previous methodology. In one study by Sayag, the use of an alginate resulted in a
significant increase in healing.6 This study compared the use of a dextranomer with an
alginate in the healing of full-thickness pressure ulcers. Wounds dressed with alginate
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healed at a much faster rate (4 weeks versus 8 weeks), and 74% of patients showed a
reduction in wound area of greater than 40%, compared to 42% of patients treated with
the dextranomer. In another study, alginate dressings were shown to substantially
improve chronic wounds.7
Alginate dressings, however, are typically used in conjunction with a secondary
dressing, which may influence the success of the dressing. In one study, the synergistic
effect of a film and alginate dressing showed more successful healing than gauze or the
individual components alone.8 Also, some alginates have been shown to reduce
keratinocyte proliferation, a key component to proper wound healing.9 “Active”
alginates have been released, displaying antibacterial properties with the addition of
silver.10 Silver-containing alginates were shown to be more cytotoxic, however, so they
are not recommended for use on non-infected wounds.9
Recent literature suggests alginate wound dressings may assist in the healing
process. Their use, however, typically necessitates a secondary dressing which could
possibly help in the wound healing process. It would be advantageous for new wound
dressings to incorporate alginate dressings’ ability to absorb exudates while maintaining a
moist healing environment.
Hydrocolloid dressings were introduced in the 1980s as an alternative to
traditional gauze dressings. Typically, they are prepared from hydrophilic colloid
particles bound to a polyurethane foam and sold under the tradenames: CarraSmart®,
Tegasorb™, Ultec®, Exuderm® LP, Duoderm®, and Comfeel® Triad, among others.1
Indications for hydrocolloids include partial- and full-thickness wounds, ulcers, necrotic
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wounds, and placement under compression wraps. These occlusive dressings are
generally comfortable, absorbent, and are an improvement over traditional dressings for
several reasons. Hydrocolloids are impermeable to bacteria and other contaminants, they
facilitate autolytic debridement, can be cut to size, and are comfortable.1,4,11 The
dressings can be self-adherent, while being non-adherent to the wound base. Dressing
changes can be less frequent when compared to gauze, and occur with reduced pain, but
the dressing can leave some residue at the wound site. Hydrocolloids are not for use on
burns, dry or infected wounds, or for heavy drainage, in sinus tracts, tunneling, or fragile
skin. Also, some studies have shown that when compared to other low-adherent
dressings, hydrocolloids applied under compression show no real advantage in the
healing of venous leg ulcers.
Even though hydrocolloids are occlusive dressings, the lack of oxygen
transmission is not problematic to healing if the wound periphery provides enough
oxygen to support endothelial and fibroblast replication.4 The occlusivity of the dressing
may be a reason for the lower reported infection rates compared to conventional
dressings. One study showed a 2.6% infection rate with hydrocolloid dressings compared
to 7.1% with traditional gauze dressings.4
There are differences in hydrocolloid dressing properties. Water vapor
transmission rates can vary by several orders of magnitude between brands of dressing.12
In a side-by-side comparison between Comfeel® and Duoderm® hydrocolloid dressings,
Comfeel®-treated wounds exhibited measurably greater epithelialization.13 Another
study comparing these two dressings showed that Duoderm® cased a larger tissue
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reaction, but no significant difference in epithelialization was seen in full-thickness
wounds in domestic pigs.14
Hydrocolloids represent a great improvement over traditional gauze dressings.
They are easy an familiar to apply, since they handle and can be cut to shape similarly to
gauze. Even though they are more expensive, the extended time between and ease of
dressing changes means less total cost associated with their application.15 They have also
been shown repeatedly to cause faster wound healing with less complications than gauze
dressings. Additionally, the adherent characteristics of many hydrocolloid dressings do
not necessitate a secondary dressing to secure the dressing to the wound.
Hydrogels were initially developed in the 1950s and are used in a wide variety of
medical devices.16 Hydrogel wound dressings are water- or glycerine-based cross-linked
polymers that are indicated for ulcers, partial- and full-thickness wounds, painful wounds,
dermabrasion, burns, and necrotic wounds.1 Virtually every dressing manufacturer has at
least one hydrogel wound dressing, and trademarks include Derma-Gel®, Nu-Gel™,
Purilon® Gel, Tegagel™, Hypergel®, Vigilon®, and FlexiGel®. These dressings are nonadherent, are easy to apply and remove, can rehydrate the wound bed, and offer traumafree removal.1,17 Hydrogel dressings aid in autolytic debridement by softening and
loosening necrotic tissue and slough. Due to the water content and high water vapor
transmission, hydrogel dressings can cause local reduction in temperature which can have
an analgesic effect. Hydrogels may require a secondary dressing to secure, and the high
moisture content can macerate periwound skin. Also, because hydrogels already contain
moisture, they cannot absorb much moisture from the wound and are not recommended
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in areas of heavy drainage. Also, due to the inability to handle wound exudates, hydrogel
dressings may require frequent changing.
Different hydrogels do exhibit variations in handling, water vapor transmission
rate, ability to handle exudates, and other properties, but some of these differences may
not lead to significant changes in efficacy.16 A key aspect is that hydrogel dressings
provide a moist healing environment and promote granulation and epithelialization in the
wound bed.17,18

In one study comparing an alginate/gelatin hydrogel covered with

sterile gauze and an elastic bandage to a control of only gauze and bandage in a rat
model, enhanced healing was seen with the use of hydrogel dressing.18 The hydrogel
dressing provided a bacteria-free environment that displayed faster wound healing with
fewer inflammatory cells.
Transparent film dressings were the first dressing to foster a moist wound healing
environment.4 Film dressings are thin polyurethane or copolymer semipermeable
membranes that allow water vapor transmission from and oxygen diffusion into the
wound bed.1,4 These nonabsorptive dressings facilitate autolytic debridement, are
impermeable to bacteria, and are generally comfortable. Indications for use include
partial-thickness wounds, pressure ulcers, superficial burns, and can be used as a primary
or secondary dressing. Some examples of film dressings include Bioclusive™,
CarraFilm™, Tegaderm™, Polyskin® II, and Opsite®. Transparent films are supplied in
many different sizes, and are generally provided with an adhesive border to allow it to
adhere to the wound margins without sticking to the actual wound. These dressings are
clear, so they allow for wound inspection without dressing removal. Additionally, they
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may require fewer dressing changes, with the dressing lasting up to 7 days.11 Studies
show that these dressings are successful in healing some wounds. One example of this
looked at the effectiveness of several dressings on standardized abrasion wounds in
young, healthy patients. This study showed the use of Bioclusive™ film dressing led to
the fastest and most complete healing of the dressings included in the study.19 Although
these dressing have many positive attributes, they can provide complications to some
wound types. They are nonabsorbent, so they should not be used on draining wounds.
Also, if not changed in timely manner, fluid buildup may lead to periwound skin
maceration.1
With the myriad of wound dressings on the market, it is obvious there is no one
“best” dressing, but some that are more suited for a type of situation, or certain doctors
prefer more than others. The goal of all wound dressings is the same – to provide the
optimum healing environment and assist in creating a wound site that approaches its
original functionality. Even with the broad range of products available, there is still
much room for improved devices, especially for more difficult-to-treat wounds such as
full-thickness burns and pressure ulcers. To improve healing in these wound types, there
have been many advances in the study of how wounds heal and the best applications for
biomaterials to assist in healing. Optimizing construct design promises to decrease
wound healing time, minimize scar formation, prevent infection, and heal wound site to
pre-injury functionality. Some materials of recent interest include biologic materials and
absorbable polymer systems in the form of membranes, foam scaffolding, gels, knits,
and, more recently, electrospun scaffolding. There has also been recent interest in

9

creating “active” devices in which the scaffold could deliver therapeutic agents. These
devices could provide antibacterial drugs, growth factors, or pain reducing drugs. By
designing a scaffold that contains many of the above attributes, it would be possible to
improve healing even in difficult wound sites.

Genesis of Electrospinning as a Fiber-Forming Process
It has been known for quite some time that electrical charge has an effect on
certain fluid systems. In 1600, William Gilbert published a work in which he described
the elongation of water droplets on a smooth surface caused by static electricity.20
Knowledge of electricity, magnetism and chemistry has expanded significantly over the
last four hundred years and the original discoveries by Gilbert were extended by many
notable scientists like Bose and Rayleigh to better understand the phenomenon associated
with liquids in electric fields.21
The process of polymer electrospinning was first patented by Formhals in 1934.2224

Over the next sixty years, this process was of limited interest and was mostly seen as a

novelty. This is because of the time expenditure and low output associated with its
production. Interestingly, several companies are currently using this technology to some
extent to produce filtration material.25 Large-scale fiber manufacturers typically employ
melt extrusion (monofilament or multifilament) to produce large quantities of yarn in an
economical time scale. For the production of small-diameter fibers, electrospinning has
been often overlooked in lieu of melt-blowing or “islands in the sea” extrusion.
However, these techniques can not be effectively used to manufacture the small fiber
diameters or controlled properties associated with electrospinning technologies.
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Additionally, many of these processes require elevated temperature, which can degrade
thermally sensitive materials. It is for these reasons that there has been recent interest in
studying and characterizing fibers made by electrospinning. A wide range of materials
have been studied for use as candidates for devices with electrospun fabric components.
The pairing of materials to the proposed applications of the final fabric is an area of
major research interest. Electrospun fabrics have been produced from materials ranging
from more-common biomedical polymers such as polycaprolactone26-28 to protein.29 The
ability to choose polymers with specific chemistries allows for the engineering of highlytailored constructs suited for individualized applications.
In 1969, Sir Geoffrey Taylor presented a paper describing the equilibrium
conditions of an electrically driven jet as caused by electrical and surface tension forces.30
This paper explored the difficulties associated with a mathematical description of the
electrospinning process. The so-called “Taylor cone” (section of electrospun jet at exit of
needle, see Figure 1.1) is named after Sir Taylor.
The electrospinning process is very complex and is best described as a chaotic
whipping motion caused by slight instabilities in a high voltage static electric field. The
fiber jet is controlled by viscoelastic and electrostatic forces.31 There have been many
efforts to mathematically describe this process, but many have relied on empirical
observations to describe processing trends.27,32 These approaches tend to vary in
complexity and have a narrow range of application. To date, the electrospinning process
is one that cannot be readily described by one or even a set of mathematical equations.
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Generalized Description of the Electrospinning Process
A custom electrospinning apparatus constructed at Poly-Med, Inc. is represented
in Figure 1.1. A polymeric solution is contained in a non-conductive syringe with a
syringe pump used to precisely control the flow rate of the solution through a blunt-end
needle. The spinning solution may be comprised of a polymer in either a melt33 or
dissolved in solvent. Solvent dissolution is the predominant method of creating the
spinning solution and is the only mode of preparation used in the subsequent studies. A
high-voltage power source provides a charge to the needle on the syringe. Electrostatic
forces caused by a static voltage differential between the needle tip and the collection
drum overcome hydrodynamic and gravitational forces in the solution; these forces cause
the polymer to be greatly attracted to the collection drum. The region known as the
“Taylor Cone” forms just outside the needle tip, where the cross section of the polymer
stream becomes very small. This diameter reduction is a result of the forces on the
solution flow coupled with solvent evaporation. Immediately after the Taylor Cone,
small variations in the static voltage field cause a chaotic axisymmetric whipping motion
in which the fiber is reduced in size to an even greater extent. The polymer is deposited
on the rotating drum until a sufficient amount is collected for analysis, typically about
1mm in thickness although thinner or thicker samples should not have substantially
altered properties.
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Figure 1.1. Graphical representation of a custom electrospinning apparatus constructed at
Poly-Med, Inc.
Parameters which affect the final electrospun construct to the greatest extent are:
solution concentration, solution flow rate, tip-to-collector distance (TCD), and voltage
differential (∆V). Another critical solution parameter is the dielectric constant of the
solution. The solution must react to an electrical potential field or electrospinning will
not occur. Generalized effects of each parameter are listed in Table 1.1 below.
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Table 1.1. General effects of basic electrospinning parameters on resulting fabric.
Parameter
Solution
Concentration
Solution
Flow Rate
TCD

Degree of
Effect
Strong
Moderate

Effect
Increased Concentration = Larger Average Fiber
Diameter
Increased Concentration = Increased Association at
Fiber Junctions

Moderate

Higher Flow Rate = Larger Average Fiber Diameter

Moderate

Increase in TCD = Smaller Average Fiber Diameter
Increased in TCD = Less Association at Fiber
Junction
Increase in ∆V = Smaller Average Fiber Diameter
Increase in ∆V = Less Association at Fiber Junction
Increase in Dielectric Constant = Smaller Average
Fiber Diameter

Strong

∆V

Weak
Moderate

Dielectric
Constant

Strong

Several studies have explored the relationship between solution polymer
concentration and fiber diameter and all have shown the same general trend: increased
solution concentration yields larger diameter electrospun fibers.34,35 Katti, for example,
has shown that through the range of polymer concentrations that are fiber forming, there
is a linear correlation with solution concentration and diameter. As the solution
concentration approached the lower end of the fiber forming range, the amount of beadlike inclusions in the fibers increased while the fiber diameter was relatively consistent.
However, on the upper end of the range, the standard deviation of fiber diameters
increased significantly.34 Solutions that have concentrations outside the fiber-forming
range will either (1) electrospray if polymer concentration is too low, resulting in a
collection of small, non-associated beads on the collection drum, or (2) drip if the
concentration is too high, resulting in the inability to collect any material on the drum.
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Solvent choice is another solution parameter affecting the morphology of the
electrospun fabric. Khil showed that changing the dimethylformamide
(DMF)/tetrahydrofuran (THF) ratio to a higher concentration resulted in increased
diameters and associations at the fiber junctions.36 Increased dielectric constant increases
the effect of the electric field, yielding electrospun fibers with smaller diameters.37 In
this case, fibers were produced from solutions with varying amounts of DMF and THF.
DMF has a higher dielectric constant than THF (38.3 v/s 7.5); solutions made with higher
ratios of DMF yielded smaller diameter fibers with all other conditions remaining
constant. Solution dielectric constant is dependant on the solvent polarity, the polymer
system, and any additives in the solution. The higher dielectric constant of DMF
overrides its lower volatility (boiling point of 153°C compared to 66°C for THF), which
one might postulate as an important factor in the final average fiber diameter. Also,
additives such as salts can contribute ions to the solution, thereby increasing the solution
dielectric constant. The viscosity of the solution could also contribute to increased fiber
association as discussed above and also in a study of melt electrospinning by Larrondo.38
In the latter case, increased extrudate temperature caused a lower viscosity of the polymer
stream, resulting in smaller-diameter electrospun fibers.
TCD and ∆V work together in that there is a threshold above which fiber
formation occurs. Previous studies have shown a decrease in the fiber diameter with
increase in voltage, but this decrease occurs over a small region at the lower end of the
fiber forming range, above which no significant change in diameter is observed.34 Katti
explains this effect as being caused by the surface charge associated with the imposed
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static electric field. Once passing a minimum value at which a “Taylor cone” is formed,
there is an initial influence of the ∆V/TCD on the final diameter which caused a decrease
in average fiber diameter from 865nm at 0.375kV/cm to 340nm at 1.0kV/cm. A further
increase to 1.25 and 1.5kV/cm yield average fiber diameters of 460 and 470nm,
respectively, with other parameters remaining constant, which indicated a complex
relationship that was not directly or solely related to the parameters TCD and ∆V.

Initial and Updated Status of Electrospinning Technology Development
Despite initial development in the early part of the century, interest in
electrospinning as a technology of biomedical interest has only risen in recent years.
Because of the renewed interest in the technology and the relative lack of application
until the late 1990s, the traditional era of electrospinning as a biomedical technology is
herethroughout designated as before 2004 and the most recent developments as being
from 2004 through the present.
Several studies have focused on describing the physical characteristics of
electrospun fibers and fabrics, which has proven to be a difficult task. There have been
many attempts to test single electrospun filaments, but these are difficult, time consuming
and do not lend themselves to testing multiple samples.39-46 This testing has included the
application of various test methods in unique ways, such as using atomic force
microscopy in tapping mode to perform 3-point bend testing and using optical
microscopes with movable stages as a means to strain electrospun fibers, to name a few.
Tan and Lim have described tensile tests of single electrospun fibers by gathering several
aligned fibers during the spinning process between two sheets and separating the sheets
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to isolate individual fibers.28 This study showed that smaller diameter fibers exhibited
higher crystalline orientation, possibly induced by the very small fiber size. Other studies
were focused on the study of properties of the bulk electrospun construct. Studies have
shown that cyclic mechanical strain assisted in the development and function of smooth
muscle tissue;47-49 from this it was determined that preparing an elastic scaffold capable
of maintaining its elasticity is an important factor when designing a scaffold for smooth
muscle cells.50 In addition, this study showed the differences in elastic recovery of
different materials, with the more elastic being better suited for growing smooth muscle
cells in vitro, thus highlighting the need for proper material selection.
The porosity of electrospun fabrics is one of the desirable features associated with
the technology. Small, interconnected open pores are formed in electrospun fabrics. The
geometry of the construct, however, makes the determination of average pore size
difficult, as the pore is not spherically shaped but is rather like a flat, non-circular
disk.51,52 When the electrospun fabric is used as a scaffold, too small of a pore size may
mean cells cannot infiltrate. One study suggests smaller electrospun fiber diameters are
linked to smaller average pore size, so minimizing the fiber diameter may not improve its
function as a tissue engineering scaffold.51
Hydrolytic degradation of electrospun fabrics and other porous constructs (e.g.
foams) have also been studied to some degree in the last few years. Many of these
materials are more traditional, for instance PGA, PLLA or PGLA copolymers. A study
of the effect of pH on foam degradation showed that microstructures of these materials
could last for months even with high-percentage mass loss.53 Another study showed that
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the degradation profile of electrospun fibers can be modulated with changes in polymer
chemistry.54 The authors proposed the rapid diffusion of degradation products (a result of
high surface-to-volume ratios) could benefit certain applications such as tissue
engineering, where the presence of these degradation products could harm cellular
growth and proliferation.
After early research studying electrospun systems comprised of a single polymer,
it was clear that there may be a need for electrospun fabrics made of two or more types of
polymers. Multicomponent systems could be of use due to the combination of materials
properties; stronger fibers could be dispersed throughout to strengthen the fabric or
polymers with different absorption rates could be interdispersed to control the mass loss
profile. Initially, fiber mixtures were produced by electrospinning different polymers
from separate syringes, creating a non-woven fabric comprised of different types of
fibers. In one such study, poly(lactide-co-glycolide) was electrospun alongside a
chitosan/polyvinyl alcohol (PVA) blend.55 The addition of chitosan/PVA fibers to the
electrospun fabric yielded a more hydrophilic material, which was shown to be more
favorable for the attachment and proliferation of human embryo skin fibroblasts. A
similar study discussed the design of mixed-fiber systems to create constructs that may be
of interest for tissue engineering.56,57 In the first case, a tube was made of type I collagen
and a segmented polyurethane to assist in maintaining the construct shape. Similarly, in a
second case mixed fibers prepared from a PVA and PLA fibers were recommended for
use in tissue engineering. One drawback of the “separate syringe” technique is the
difficulty in producing a uniform mixture of the different fibers throughout the fabric. A
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proposed method for creating uniform mixtures is by combining the spinning materials in
the same solution.
In some instances, it has also been shown that development of surface chemistry
that is different from the bulk composition is possible. This may be attributed to the high
voltage field or solvent evaporation effects during the spinning process. In one study, a
series of random fluorinated copolymers were electrospun with no post-spinning
treatments.58 These fibers exhibited a significantly higher concentration (approximately
double) of fluorine-bearing chains near the surface than in the bulk of the fibers.
Traditionally, fibers with surfaces different from the bulk could only be produced by
complex bicomponent melt-extrusion or melt-blowing processes or chemical posttreatments.59 This shows that electrospinning provides a means for the formation of
microfibers with specific surface characteristics that can differ from the bulk material. A
material may be used as a carrier for another material that may or may not be fiberforming. Moreover, electrospinning has been shown to be an effective means of
incorporating insoluble materials into nonwoven fabrics. Calcium carbonate and
hydroxyapatite have been incorporated in electrospun fibers as a means for assisting in
cellular adhesion and proliferation60-62 with promising but mixed results. Traditional
materials have been enhanced with the addition of particlulate; for instance, silver
nanoparticles have been incorporated as a means to form anti-odor/antimicrobial fibers.63
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Traditional and Contemporary Applications of Electrospinning and Production of
Microfibrous Biomaterials and their Clinical Relevance
Advances in the field of Biomedical Engineering have increased interest in
electrospinning technology. Research in electrostatic spinning has followed a nearly
exponential rise in activity since 2000.64 The electrospinning process is, in general, a
very benign process that allows for the production of micro- and nano-scale fibers from
certain fiber-forming materials, as well as traditionally non-fiber forming materials. This
is of specific interest to the biomedical community because of the opportunity to design
highly-tailored novel constructs with a multitude of possible uses. Some proposed uses
for these materials, and particularly the absorbable type, include in vitro and in situ tissue
engineering scaffolds, wound dressings, drug delivery devices, haemostatic aids, wound
covers, pledgets and endovascular stent covers. The majority of the work to date has
been focused on development of traditional non-bioabsorbable systems or bioabsorbable
systems exhibiting moderate to high tensile modulus and, hence, low compliance.
Electrospinning technology has been well-known for some time; however, recent
advances in bioengineering have prompted the exploration of its use for new classes of
materials. A key aspect in the decision to apply electrospinning technology for a new
biomedical device is the significance of the sought final products. The process of
electrospinning is simply a means of converting novel polymers of biomedical interest
having unique properties into a fabric with enhanced or new clinically significant
properties; the pairing of constituent material(s) to the proposed application becomes the
ultimate contributor to the success of the device.
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Current research in electrospinning technology for biomedical applications can be
classified into two main categories: characterization of electrospun fabrics and
exploration of technology for use in biomedical devices. The former deals with the study
of fabrics made by electrospinning and the properties of the resulting fabrics, including
those introduced by the spinning process, additives to the polymer solution, and fabric
treatments. The latter category deals with the application of electrospinning technology
and the use of fabrics made thereby in various applications. Both categories are
important and are addressed to some degree in the completed and proposed studies, with
the emphasis being on the characterization of novel electrospun fabrics.
A fast growing application of electrospun fabrics is for use as tissue engineering
scaffolds and, by extension, wound dressings. For a scaffold or dressing to be successful,
it must be capable of meeting two major requirements. Firstly, the scaffold must supply
the mechanical support structure while cells are developing and must transfer that load to
the cellular matrix in a timely manner to induce a proper load-bearing cellular structure.
Secondly, the scaffold must not hinder proliferation and extracellular matrix production.
This could be accomplished through imparting specific surface chemistries and
topographies which are suitable for cellular attachment and in-growth. Electrospun fibers
have an advantage in that cells attach and organize themselves around fibers with
diameters smaller than that of the cells.65 Much of this work parallels work done on
porous polymeric foams, but the process of electrospinning has an advantage in the
uniformity of pore sizes and fiber diameters and the minimized residual impurities from
the spinning process when compared to foaming processes. Some research is focused on
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developing scaffolds from materials known to support specific cell cultures. For
example, ethylene vinyl alcohol copolymers (EVA) have been shown to support smooth
muscle cell and fibroblast growth, and electrospun scaffolds provide a simple method for
the preparation of porous scaffolds.66 The coupling of EVA with electrospinning
technology is just one example of the conversion of available polymers to a fabric that
may have enhanced properties.
In order to tailor the properties of electrospun fabrics for specific uses, the method
of production is paramount to the modulation of these properties. For instance, in order
to improve the quality of healing of ligament tissue, electrospun fibers were collected on
a drum spinning at high speed, which resulted in highly-aligned fibers.67 Increasing the
extent of fiber orientation yielded increased projected cell area and aspect ratio, thereby
improving the efficacy of the scaffold. This is a result of what the respective authors
referred to as “regulation of spacial distribution of adhesive contacts and the direction of
cell spreading.” An interesting find of this study is that cellular growth performance was
enhanced on fabrics with larger-diameter electrospun fibers (3.6µm compared to 0.14 and
0.76µm). However, in another study neural stem cell differentiation was shown to be
enhanced with nanometer-sized fibers over larger diameter fibers,68 further showing the
importance of determining optimal fabric properties for each application. These studies
both show electrospinning as holding promise in the development of scaffolds for tissue
types such as collagen for ligaments,67 musculoskeletal,69 or neural cells.68
Electrospun fabrics have also been compared to more-traditional textile constructs
such as knitted fabrics for use as scaffolds. For instance electrospun and knitted
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polycaprolactone scaffolds were compared for use in engineering an aortic valve.26 The
electrospun scaffold did not have the strength of the knitted version. However, the
respective investigators reported that a combination of the two may have enhanced cellseeding properties when compared to the individual components. Surface modified
polyethylene terephthalate (PET) has also been studied for use as a tissue scaffold.70 This
study determined the positive effects of having a hydrophilic surface on the in-growth
and proliferation of cells on the scaffold. The surface modification entailed a
formaldehyde treatment that allowed surface carboxylation of the PET, causing a shift
from an intrinsically hydrophobic to hydrophilic scaffold. This was responsible for the
improved cellular growth response. The aforementioned studies support the thesis that
electruspun fabrics hold great promise as tissue engineering scaffolding.
For wound dressings, several factors indicate the possible advantages of using
electrospun fabrics. In order for a wound to heal properly, the wound dressing must
protect from microorganisms while allowing oxygen permeability and fluid exudation.
Polyurethane, which has been shown to produce effective wound dressings in the past in
the form of thin films,71 has been studied as a wound-healing electrospun membrane.72
And, the electrospun membrane exhibited increased epithelialization rate over the
Tegaderm™ control, once again showing fabrics made by the electrospinning process are
good alternatives to more traditional technologies.
For a medical device to be approved for clinical application, it must pass a
rigorous set of tests which assert the safety of the device. Wound dressing devices can be
categorized as a surface device for breached or compromised surfaces. The choice for
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absorbable materials is generally made with the goal of not retrieving the device after
placement. Although the material degrades over time, this is defined by ISO 10993-1 as
being a permanent device placement because the degradation process is typically longer
than 30 days.73 Testing required for this type of device includes: cytotoxicity,
sensitization, irritation, subchronic toxicity and genotoxicity. Generally, initial screening
of the material and/or device is performed through in vitro cyctotoxicity testing. While
cytotoxicity does not provide enough evidence to conclude device biocompatibility, it can
be used as an early indication that extractables from a material could be harmful to
cells.74

Common cytotoxicity testing includes exposing a confluent monolayer of cells

to eluents from incubated materials. In another method, the test material is placed on a
protective overlayer (e.g. agar) and the extractables are allowed to migrate to the cell
layer. This is known as a “direct contact” method. For both eluent and direct contact
methods, cells are stained to visualize any harmful effects of the extracts on the cell layer.

Contemporary Uses and Adopted Strategies for the Effective Application of
Electrospinning to the Preparation of Clinically Useful Forms of Biomaterials
In order for any material to be used in the medical field, the material must
withstand traditional sterilization cycles without significant degradation of the product
performance. Typical methods of sterilization include γ-irradiation, ethylene oxide gas
permeation, steam and e-beam sterilization. Sensitive materials such as absorbable
polymers may be damaged by some of these sterilization methods and, as a result, the
sterilized device may be partially defective with less-than-predictable behavior. Gamma
and e-beam sterilization protocols have been shown to negatively affect the molecular
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weight and strength of poly(l-lactide) and poly(l-lactide-co-glycolide) polymers, while
other treatments such as cold gas plasma and ethylene oxide sterilization do not have as
great an effect.75-79 Polymers that are more susceptible to hydrolytic degradation, i.e.
faster absorbing glycolide copolymers, exhibit the greatest damage during radiation
sterilization. Other material properties that could be affected by sterilization include
degradation profile, thermal properties and morphology.80 The susceptibility of
electrospun fabrics to sterilization-induced property degradation is increased as a result of
the micro-/nanoscale architecture associated with these constructs. An alternative to
traditional radiation sterilization protocols is the radiochemical sterilization process. This
is a low-dose radiation sterilization process developed specifically for absorbable
polymers.81,82 Radiochemical sterilization employs low levels of γ-radiation sufficient
for effecting the internal sterilization of a device while radiolytically generating
formaldehyde for surface sterilization.83 This process has been shown to be an effective
alternative to traditional γ-sterilization of absorbable sutures with little damage to the
material properties.84
There has been a significant amount of attention given to the development of
electrospinning technology, yet there are several areas that are yet to be explored. It has
been shown that material choice is a key aspect in engineering design and polymer choice
for electrospinning with biomedical applications is important for the ultimate success of
the construct. Many of the polymeric materials used in the prior art are commerciallyavailable and are non-absorbable or lack compliance (stiff and brittle). Electrospinning
can produce fabrics from these materials that have better handling properties than other
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production methods (e.g. meltblowing or microfoaming), but the use of novel materials
that are clinically significant and inherently compliant could form scaffolds with unique
physical properties.

Factors Affecting Cellular Proliferation and Unmet Needs of Current Electrospun
Materials as Incentive to Pursue Current Research
Many proposed uses of electrospun fabric in biomedical applications involve
contact of the fabric with biological materials, e.g. wound dressings. In this case, it is
imperative that the dressing not harm the contacted tissue or host cells. One way to
assure the compatibility of the substrate with surrounding tissue is to modify the surface
with a material that is considered biocompatible. This could be in the form of a coating
to hide the underlying substrate from living tissue or surface functionalization to impart a
specific chemistry to the surface. These surfaces can be sensitive to abrasion, stress
fracture, chemical interactions, or other factors which can decrease their effectiveness in
imparting enhanced biocompatibility. Ideally, the primary component would be
inherently biocompatible so that additional measures would not be necessary. This can
be accomplished by first creating the material from clinically-acceptable constituents,
which are known to be biocompatible. A substrate created from these materials must
then be designed to have acceptable surface topography and crystallinity to optimize the
reaction with surrounding tissue. By engineering these surfaces to obtain desirable
attributes, substrates can be optimized for their designed use.
Surface topography can affect cellular response on every level, and is dependant
on cell type. Cellular activity is positively affected on surface features of the same
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approximate size as that of the cell.85

Topography can also affect the orientation of new

cell growth. With aligned topographical features on the micron level, fibroblasts grow
along surface grooves. On smoother surfaces, cells proliferated in no particular
orientation.86 In one study, osteoblasts were seeded on the surface of PLA films prepared
with varying levels of roughness. Results indicated a significant decrease in osteoblast
proliferation with surface roughness greater than 1.1nm RMS.87 Another recent study on
the effects of surface roughness on the proliferation of human bone osteoprogenitor cells
determined that decreasing the surface roughness from 5µm to 1.2µm greatly increased
the percent coverage of cells on a titanium substrate.88 Above 5µm, the percent cell
coverage was approximately the same. On a silicon surface, an optimum range of surface
roughness from 20-100nm RMS resulted in the greatest adherence of rat embryo neural
cells.89 It is difficult to isolate the effect of surface roughness, however, as many surface
factors are interrelated. By changing the annealing conditions in a PLA material,
crystallite size and surface roughness are affected.87 The effect is dependant on cell type,
however. In hydroxyapatite, it has been shown that lower crystallinity allowed greater
osteoblast adhesion, similar to RGD functionalization.90 In the same study, higher-thannormal crystallinity also caused an increase in osteoblast adhesion. These changes could
be from the effect of crystallinity on surface free energy and polarity, as was the case in a
study on chondrocyte activity on the surface of polyhydroxyalkanoate blends with
varying crystallinity.91 Zheng, et. al., showed that chondrocytes bound better with higher
surface free energy, which was related to the material crystallinity. Additional studies
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show that, from osteoblasts to fibroblasts, substrates with lower surface crystallinty create
a more compatible environment for cellular activity.92-95
In general, it seems that for most materials a surface with lower crystallinity is
more suitable for cellular adhesion and proliferation. From the literature, it is not clear if
this is more associated with surface hardness, roughness, free energy, or other changes
associated with differences in crystallinity. All of these aspects are interrelated, which
makes the isolation of one parameter virtually impossible.
To date, most research on electrospinning has focused on simple singlecomponent systems created from commercially available polymers or slightly modified
versions therefrom. Although electrospinning technology can convert these materials
into a scaffold, the available materials may not optimally meet the requirements of the
sought application. The development of an electrospun scaffold prepared from a highlycompliant and fast-absorbing class of novel polymers prompted the initial stage of study.
Many materials have attractive biological properties but are difficult to process
because of poor physical properties. Hydrophilic materials are, in general, difficult to
process, but the use of hydrophilic materials in electrospun scaffolding could prove
beneficial because the final material surface that have higher water affinity, which has
been shown suitable for tissue engineering purposes.96-98 Many commonly-used
biodegradable polymers are inherently hydrophobic, so techniques have been developed
to impart a hydrophilic surface on constructs made from these materials.99,100 These
treatments, however, can damage the material yielding a less-effective device.
Polyethylene glycol (PEG) is material often used to form hydrogels for use in tissue
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engineering, but it lacks the strength to form stable solid constructs. This creates an
opportunity for electrospun systems incorporating materials with good mechanical
properties and materials with biologically relevant chemistry. This will be useful in
achieving precisely tailored properties of the specific system and increase its clinical
relevance.
Additionally, some researchers have studied the incorporation of special additives
into electrospun fabrics, constituting both soluble and insoluble materials. These
additives have been in the form of drugs, insoluble ceramics, and other polymers to form
electrospun fabrics with specific attributes. Various drugs have been incorporated into
electrospun fabrics. However, the drugs were chosen based on proposed applications and
all showed variations in release profile. Limited work has been done to determine the
cause for the differences in release profile. Inorganic materials have been incorporated in
electrospun fabrics so that the fabric could act as a carrier for these materials. Factors
and methods affecting the uniformity of the dispersion of inorganic and organic materials
have yet to be fully explored.
The amount of recent interest in electrospinning technology has yielded a large
amount of research, but it is clear that there are still many aspects of this technology left
to be studied. The goal of this research is to find novel applications for electrospun
fabrics and develop methods for the creation and testing of these fabrics with uniquely
tailored, clinically relevant properties for use in biomedical engineering, including
possible uses in clinical applications.
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CHAPTER 2
ELECTROSPINNING OF ABSORBABLE POLYAXIAL SEGMENTED
COPOLYESTERS AND STUDY OF FACTORS AFFECTING THEIR PROPERTIES

Introduction
In recent years, a great deal of attention has been given to electrostatic spinning.
Although the origins of the technology are rooted in the 1930s, electrospinning did not
garner much interest until the mid- to late-1990s, paralleling many advances in the field
of Bioengineering. Electrospun fabrics have been proposed for use in many applications,
including tissue engineering scaffolding, wound dressings and various other biomedical
devices. In particular, much attention has been paid to the use of these fabrics as tissue
engineering scaffolds. Past research has shown that biodegradable polymers can be used
as scaffolds for culturing different types of cells.1-4 Additionally, cells have been shown
to organize well around materials with topographic features that mimic the nanoscale
dimensions of native extracellular matrix.5 Electrospun fabrics have just such
topography, can be made from clinically accepted classes of absorbable materials, and
can be manufactured with very high porosities and tensile elongations, which can be
beneficial to tissue engineering scaffolding by allowing cellular ingrowth and load
transfer to enhance cellular orientation. Morphology is not the only factor which
determines the suitability of a device for cell growth scaffolding. Other
physical/chemical characteristics, such as material biocompatibility, crystallinity, and
surface chemistry are major determinants for cellular attachment and proliferation. For
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these reasons, scaffolds must be constructed from biologically compatible materials and
be designed to have the proper surface for the proposed application.
One major clinical use for tissue engineering scaffolding is in wound healing
applications. Tissue engineered scaffolds could be of particular interest for burn wounds,
ulcers, or any wound with a large surface area. The optimum wound dressing maintains a
moist environment to assist in the migration of epithelial cells.18 Additionally, wound
dressings should act as a biological barrier to guard against infection, promote rapid
healing, and provide autolytic debridement. For clinical acceptance, however, the
dressing must also decrease pain, require fewer changes, and be cost-effective.
Sterilization of the materials complicates the translation of absorbable polymers to a
clinical setting. Typical laboratory and clinical sterilization includes γ-irradiation,
ethylene oxide gas permeation, steam, or e-beam sterilization. These protocols may
damage sensitive absorbable polymer structures, leaving a partially defective device of
less-than-predictable performance. Applying gamma and e-beam sterilization protocols,
the mechanical strength and intrinsic viscosity of poly(l-lactide) and poly(l-lactide-coglycolide) polymers are significantly affected, while cold gas plasma (CGP) and ethylene
oxide sterilization do not have as great an effect on the properties of these fibers.6-10
Effects are greater in polymers that can easily undergo hydrolytic degradation, i.e. faster
absorbing glycolide copolymers are more susceptible to degradation as a result of
sterilization than polymers containing only l-lactide-based sequences. Sterilization
affects other properties of the fabrics, such as degradation rate, thermal profile, and
morphology. CGP treatments, for instance, have been shown to cause surface roughness
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in some absorbable materials.11 Radiochemical sterilization is an alternate form of
radiation sterilization developed specifically for sensitive absorbable polymers. This
process involves irradiating a hermetically-sealed foil pouch containing the material to be
sterilized with low levels of γ-radiation (5-15kGy). An additional material in the packet
radiochemically produces formaldehyde gas at an effective level for sterilization.
Radiochemical sterilization has been shown to be an effective alternative to sterilize
absorbable sutures without significantly damaging the material properties.12 A novel
sterilization protocol developed at Poly-Med, Inc. has therefore been chosen as a possible
method of sterilizing these sensitive fabrics.
The first stage in this research was to construct an electrospinning unit suitable for
further modification. The effectiveness of this unit for electrospinning fabrics was
established using polycaprolactone as a traditional control polymer and experimental
polymers of growing biomedical significance coupled with traditional solvents and
traditional electrospinning conditions. Secondly, techniques were determined for testing
biomedically relevant properties of these fabrics. Finally, the effects of basic processing
conditions on fabric properties were studied.

Materials and Methods
Polycaprolactone (PCL) (Dow Chemical) was obtained for use as a linear,
crystalline “absorbable” polyester material with electrospinning characteristics similar to
novel polymers of clinical interest designed and manufactured at Poly-Med, Inc. PCL
has been used as a biomedical material in the past.13,14 PAX-2 and PAX-6, crystalline,
absorbable, segmented polyaxial copolyesters, were manufactured at Poly-Med, Inc. by
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end-grafting l-lactide onto an amorphous polyaxial polymeric initiator, and were used as
polyaxial elastoplastic copolyesters.15,16 The polymers show increasing degrees of
softness and absorption rate with PAX-2 as the harder (less compliant) and slower
absorbing and PAX-6 as a softer (more compliant) material with a faster degradation
profile.
Electrospinning solutions were made from 10-25 w/v% polymer with
dichloromethane (DCM) and/or chloroform (CHCl3) as solvents by rolling components
on a jar roller at room temperature until dissolved. Polymer solutions were transferred
into a plastic, non-conductive syringe and placed in a syringe pump. The pump is used to
precisely control the flow of solution through a 20-gauge blunt end needle. A highvoltage power supply (Matsusada) is used to create a 15kV static charge between the
needle and a stainless steel collection plate, with a tip-to-collector distance of 7”.
Variations in fabrics from the same materials were made by modulating the polymer
solution concentration and solvent volatility.
In order to test the electrospun fabrics for stability through a sterilization cycle,
fabrics underwent several sterilization protocols. Samples measuring 2" x 2" were
hermetically sealed in individual foil pouches in an inert atmosphere. The pouches
measured approximately 3” x 3” and thin card stock cut to the sample size was included
in the pouch to act as a desiccant. Sealed samples were γ-sterilized at 20 or 25kGy or
radiochemically sterilized at 5, 10, or 15kGy in the presence of formaldehyde gas
radiochemically generated from a 150mg packet of Celcon®.
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To analyze thermal transitions, differential scanning calorimetry (DSC) analysis
was employed using a Perkin-Elmer DSC-6 to obtain the melting temperature (Tm), heat
of fusion, and width of the melting endotherm at half height (Whh). Inherent viscosity
(IV) was measured using a Cannon-Fenske viscometer with chloroform as a solvent.
Molecular weight was determined by gel permeation chromatography (GPC) with a
DCM mobile phase, Styragel® columns, and a Waters 2414 refractive index detector.
GPC data was analyzed for the number average molecular weight (Mn), weight average
molecular weight (Mw) and the polydispersity (PDI). Fabric morphology was obtained
through scanning electron microscopy (SEM) analysis with a Hitachi S3500-N SEM
system and fiber dimensions were obtained by measuring the width of the fibers as seen
by SEM and comparing to a scale on the SEM plot. Data from at least 20 random fiber
diameter measurements were averaged and reported with one standard deviation;
differences in diameter were calculated using an unpaired Student’s T-test. Additionally,
selected samples were analyzed by tilting the SEM sample table to 58° in order to obtain
an oblique view of the fabric. Mechanical burst testing of the fabric samples was
accomplished using an MTS Synergie 200 testing system with a 3/8" hemispherical
plunger and a 1-3/4" specimen diameter. Burst testing was completed at a plunge rate of
1mm/s until failure. For comparison of burst strength, data points were plotted using
Microsoft® Excel and correlated using a linear least-square fit algorithm in which the
slope of the line and R2 value was obtained. Similarly, data comparing the effects of
irradiation on fabric properties were compared with a linear least-square fit algorithm.
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PAX-2 and PAX-6 fabrics were tested for possible cytotoxic effects. Samples
were sterilized by dipping in ethanol and allowed to dry in a laminar flow hood for 1 hour
and dried for an additional hour under vacuum.
L929 Fibroblasts (ATCC, Manassas, VA, passages 5 thru 8) were used for the
cytotoxicity study. Cell cultures were maintained at 37°C in a humidified, 5 % CO2/95%
air environment. Media was changed every 2 to 3 days. Complete media consisted of
Minimal Essential Medium, Eagle (ATCC, Manassas, VA) supplemented with 10% horse
serum (ATCC, Manassas, VA) and 1% penicillin/streptomycin (Invitrogen).
A 1.6% agarose solution was prepared and mixed (1:1) with complete media to
create a “soft agarose”. Components and solution were maintained at 45 ºC to prevent
agarose from solidifying. A dilute solution of neutral red dye (0.01 %) was prepared by
diluting the stock solution (1.4%, Sigma) with phosphate buffered saline (Sigma).
Fibroblasts were seeded at a density of 6.0 x 104 cells/cm2 (384,000 cells/mL) in
6-well plates and incubated at 37°C at 5 % CO2 for 48 hours. At that time, media was
aspirated and “soft agarose” was gently pipetted onto the cell layer. Plates were incubated
at 37 ºC for 30 minutes to allow the agar to solidify. At that time, 0.01% neutral red was
added on top of the agar and incubated further at 37 ºC for 30 minutes. Neutral red was
then aspirated from each well, being careful not to disturb the agar layer. Test materials
and control materials were added as the top layer to each well. Samples were prepared in
triplicate (one sample per well). Plates were then incubated for 24 hours and observed by
microscope. Digital images were taken to make qualitative observations. The absence of
sample was used as a negative control and pieces of copper wire (0.4mm diameter, 1cm
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long) were used as a positive control. Neutral red stain is transported across active cell
membranes by endocytosis and is absorbed into lysosomes. In an acidic environment,
such as the one maintained in lysosomes, neutral red maintains a characteristic red color.
In non-viable cells that cannot maintain acidity around lysosomes, neutral red acts as a
titrating indicator and changes to a transparent yellow; as such, it is used as an indicator
for cell viability.

Results and Discussion
2.1 Application of electrospinning techniques to biomedically relevant traditional and
novel polymer systems

SEM analysis showed that the electrospinning of PCL successfully produced
continuous strands of microfibers in a characteristic non-woven pattern, as can be seen in
Figure 2.1. Random samplings of the cross-sectional diameters show the microfibers
with a mean diameter of 8.4±1.1µm. PCL was used as a model system because of its
thermal and solution stability and its historical significance as a biomedical material.
Table 2.1 describes the effect of electrospinning on the thermal properties and molecular
dimensions of this PCL non-woven fabric. The molecular weights, as determined by
GPC analysis, of the pre-spun material and the electrospun fabric were virtually identical.
These results were consistent with the viscosity data, which also showed no significant
reduction in IV. Thus, data suggests that the electrospinning process did not significantly
degrade the PCL. Considerable differences were seen in the DSC data of the two
materials. A significant decrease occurred in the melting temperature (Tm) and the
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endotherm width at half height (Whh), as measured in terms of associated temperature
span, while a slight increase occurred in the heat of fusion (∆Hf). Whh may be correlated
directly to the crystallite size distribution in the sample. A decrease in the Whh indicates
a narrowing of the crystallite size distribution. It was thus determined that the small fiber
diameters created during the electrospinning process led to increased crystallization in the
linear material. Graphically, the changes in thermal profile can be seen in Figure 2.2.
The decrease in Whh is a result of the small fiber diameters formed in the spinning
process inhibiting crystallite growth and the force applied to the fibers by the highvoltage electric field, causing the polymer chains to orient axially in the fiber and a high
degree of nucleation to occur during crystalline formation. This orientation leads to
small, highly uniform crystallites. The smaller crystallite size present in the electrospun
fabric resulted in the reduction of the melting temperature.

Figure 2.1. Electrospun PCL fabric showing long fiber lengths in a non-woven pattern.
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Table 2.1. Effect of electrospinning on the thermal properties and molecular dimensions
of PCL fabric, data obtained from one specimen per sample.

Processing Stage
Pre-spinning
Electrospun fabric

Molecular Weight
Mn
Mw
PDI
(kDa) (kDa)
88
128
1.45
90
119
1.32

Viscosity
(dL/g)
1.30
1.29

Thermal Characteristics
Tm
∆Hf
Whh
(°C)
(J/g)
(°C)
69
52
12.7
58
55
5.9

14
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Electrospun PCL Fabric
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Figure 2.2. Effect of electrospinning on the melting transition of PCL.

PAX-2 was the first of the PAX materials processed and was used to determine
the ability of this class of material to form electrospun fibers. The polymer was initially
electrospun at 20 w/v% with DCM as solvent, a 15kV voltage differential, and 7" TCD to
mimic the previously described PCL processing conditions. The PAX-2 material, a
highly compliant polyaxial elastoplastic, exhibits little tendency to crystallize. The
average fiber diameter produced under the above conditions was calculated to be
7.0±1.8µm. The broader distribution of fiber sizes (when compared to PCL electrospun
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fabric) could be related to slower crystallite formation during the spinning process. Table
2.2 shows the effect of electrospinning on the thermal properties and molecular weight of
PAX-2. A slight increase in molecular weight and decrease in viscosity does not indicate
any substantial process-induced degradation from solution preparation or electrospinning.
PAX-2 shows a low propensity to crystallize, either in the bulk material or the
electrospun fabric. Chain entanglement in the polyaxial polymer causes this inhibition in
crystallization. Physically, chain entanglement resulted in the melting transition
remaining unchanged with only a slight decrease in the heat of fusion. The Whh
decreased by 12% from electrospinning, with only a slight decrease in the crystallite size
distribution. These results show the efficacy of producing electrospun microfibers from
PAX-2; the methods may be extended to produce several PAX polymers of varying
composition and physical/chemical properties.

Table 2.2. Effect of electrospinning on the thermal properties and molecular dimensions
of PAX-2 fabric.

Processing Stage
Pre-spinning
Electrospun fabric

Molecular Weight
Mn
Mw
PDI
(kDa) (kDa)
81
114
1.41
91
133
1.46

Viscosity
(dL/g)
1.02
0.92

Thermal Characteristics
Tm
∆Hf
Whh
(°C)
(J/g)
(°C)
159
25
9.9
159
18
8.9

2.2 Modulation of initial electrospun fabric properties by varying solution composition

PAX-2 was spun at 15, 20 and 25 w/v% from identical solvent compositions to
determine the effect of solution concentration on fabric properties. Data in Table 2.3
further indicates the inhibition of crystallization in PAX-2 electrospun fabrics and shows
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dependency of this inhibition as a function of the concentration of PAX-2 in solution;
further effects of concentration include changes in the resulting fiber diameter. It was
found that lower polymer concentrations yield significantly smaller diameter fibers.
Microfibers spun from 15 w/v% solution were less than half the diameter of those spun at
25 w/v%, with a 2-tailed p-value of .0005 indicating the sets have significantly different
diameter. This decrease occurs because the low polymer concentrations extruded into the
electric field are under similar forces, and more volatiles are lost by increased solvent
fraction, leading a reduction in the amount of fiber-forming material. Similar effects are
seen in wet spinning processes. Fiber diameter is limited on both ends of the spectrum by
a “critical” concentration that will no longer produce microfibers; low concentrations
produce electrospraying and high concentrations create a solution stream in which the
electrostatic force is not significant enough to overcome the force of gravity. In solutions
with concentrations on the upper end of the fiber-forming range, larger fiber diameters
are produced whose properties more closely mimic those of the bulk material. This
observation is evident in the increase of the heat of fusion with increasing microfiber
diameter, which shows that the crystallization in PAX-2 is hindered by smaller diameter
fibers. Further evidence of this observation is the decrease in Whh with decreased
microfiber diameter, indicating more uniformity in the crystallite size, but this may also
be linked to the reduction in the heat of fusion. The melting temperature remained
constant with each fabric, demonstrating that there was no additional nucleation and
subsequent forced crystallization induced by the electrospinning process.
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Table 2.3. Effect of PAX-2 solution concentration on final fabric properties.
Solution
Concentration
(w/v%)
15
20
25
Bulk Polymer

Thermal Properties
Tm (°C)

∆Hf (J/g)

Whh (°C)

Fiber Diameter
(µm)

160.0
159.1
160.4
159.2

18.0
18.4
18.8
25.2

6.6
8.7
9.0
9.9

4.1±1.6
7.0±1.8
8.3±0.7
n/a

In addition, changes in the initial properties of PAX-2 electrospun fabrics as a
result of solvent composition were studied. This study was accomplished by using
different mixtures of DCM and CHCl3, and creating solutions of varying volatility
according to the Gibbs phase rule. DCM boils at 40˚C while CHCl3 boils at 62˚C
therefore, solutions become more volatile with increased levels of DCM. The fabrics
were produced under otherwise identical conditions, with 20 w/v% PAX-2 in solution,
15kV voltage differential, and 9" TCD. Table 2.4 shows the properties of these fabrics
after spinning. Solutions prepared with high concentrations of CHCl3 were not fiberforming, indicating some dependence between solvent choice and final material
characteristics. Molecular weight data shows no substantial difference in the degradation
of the material through processing with different solvent compositions. SEM analysis of
samples taken with a table angle of 58° shows some differences between fabrics spun
with different solvent volatilities (Figure 2.3). A visual difference between the three
fabrics is the degree of interlayer packing. The fabric in 2.3(a), spun using only DCM as
a solvent, does not appear as tightly packed as other fabrics. In contrast, fabric prepared
from an equal ratio of DCM and CHCl3 appeared to yield tighter-packed layers of
microfibers. The less-volatile solvent in the latter fabric acted as a plasticizer and
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allowed the microfibers to stay more deformable as they were deposited on the alreadyspun microfiber layers. Other authors have reported increased fusion at fiber junctions
with decreased solution volatility,17 but this phenomenon was not seen consistently in
fabrics involved in this study. Further analysis of SEM results show that the different
solutions did not produce significantly different microfiber sizes. Another possible
indicator of increased fusion at fiber junctions is the burst strength, where fabrics
showing increased fusion at fiber junctions should display greater load at burst. Fibers
produced from solutions having increased volatility, however, did not show a special
trend in the values of the burst strength. Meanwhile, there were differences in the burst
strength of the fabrics, but the data did not exhibit a strong linear correlation (R2 value of
0.61) . DSC data show no substantial changes in the thermal properties of the fabrics,
which indicates that the thermal characteristics of these single-component electrospun
fabrics are based on the final microfiber dimensions and are independent of the solvent
volatility of the solution, under the prevailing conditions.

Table 2.4. Effect of solvent volatility on properties of PAX-2 electrospun fabrics from 20
w/v% solution with 15kV ∆V and 9" TCD. Strength reported with average and one
standard deviation.
Fiber
Ratio
Diameter
DCM:CHCl3
(µm)
4:0
3:1
2:2
1:3
0:4

5.8±1.9
5.6±0.7
6.7±1.2

Molecular
Melt Properties
Burst
Dimensions
Strength
Tm
Mw
∆Hf WHH
Mn
(N/mm)
PDI
(kDa) (kDa)
(°C) (J/g) (°C)
101.5 173.7 1.71 160.7 19.7 7.3
121±9
100.8 170.3 1.69 160.2 16.7 6.7
91±4
99.4 168.2 1.69 160.2 17.5 7.1
129±5
Not fiber-forming
Not fiber-forming
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a

b

c
Figure 2.3. SEM images o fPAX-2 electrospun fabric spun at 20 w/v%, 15kV ∆V, 10" TCD with
(a) DCM as solvent, (b) 75% DCM / 25% CHCl3 as solvent and (c) 50% DCM / 50% CHCl3 as
solvent. Images taken on Hitachi 3400N SEM at 58° table angle.

2.3 Effect of the radiation sterilization protocol on PAX-2 and PAX-6 and PCL control
fabric

PAX-2, PAX-6 and PCL electrospun fabrics were prepared from similar solutions
and irradiated to determine the effect of several sterilization protocols on the molecular
dimensions, thermal transitions and rupture properties of the three materials. The
materials were gamma sterilized at 20 and 25kGy and radiochemically sterilized (RCS) at
5, 10 and 15kGy, as discussed above. Table 2.5 summarizes the thermal properties and
molecular dimensions of the three fabrics after irradiation. The data indicates some
change in the measured properties of the control PCL fabric. A general decrease in the
Mn is observed as the radiation dose increases, an effect which was also seen in the Mw
values. PDI increased with increasing γ-dose, indicating a broadening of the range of
molecular weights. The viscosity showed a general decrease as well, indicating
increasing levels of degradation with increased irradiation. The molecular dimensions
remained fairly constant under RCS conditions using a 5kGy radiation dose, showing
very little process-induced degradation associated with this sterilization protocol. 25kGy
irradiation dose showed the most significant change in viscosity and molecular weight,
with a 22% decrease in the molecular weight and a 6% reduction in viscosity.
Meanwhile, thermal data show small changes as well. An increase in Whh indicates a
broader range of crystallite size and correlates well with the supposition of polymer chain
degradation.
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Table 2.5. Irradiation effects on thermal properties and molecular dimensions of PCL,
PAX-2 and PAX-6 electrospun fabrics prepared from 20 w/v% solution.

Material

PCL

PAX-2

PAX-6

Irradiation
Level (kGy)
0
5
10
15
20
25
0
5
10
15
20
25
0
5
10
15
20
25

Molecular Weight
Mn
(kDa)
103.2
98.1
91.8
88.9
85.5
80.9
79.9
90.2
81.8
72.0
71.7
64.3
127.8
137.2
114.3
104.2
94.6
82.0

Mw
(kDa)
160.0
154.8
150.7
146.2
144.2
139.9
219.5
227.9
211.6
190.0
182.9
175.9
354.7
388.8
315.8
293.2
275.7
260.1

PDI
1.55
1.58
1.64
1.64
1.69
1.73
2.75
2.53
2.59
2.64
2.55
2.74
2.78
2.83
2.76
2.81
2.91
3.17

Viscosity
(dL/g)
1.14
1.14
1.10
1.07
1.07
1.04
1.02
0.93
0.85
0.81
1.61
1.42
1.27
1.06
0.99

Thermal
Characteristics
Tm
∆Hf Whh
(°C) (J/g) (°C)
61.3
93
5.7
61.7 103
6.1
61.6 105
6.0
61.3 109
6.0
61.5 110
6.0
61.7 104
7.0
161 27.4
6.9
161 27.3
6.9
162 25.7
6.6
162 25.0
6.4
162 28.8
6.3
162 26.2
6.2
151
8.2
15.4
152
8.8
14.1
155
9.9
13.3
156 10.7 14.2
156 10.6 13.8
157
6.9
12.8

Data from Table 2.5 also show decreases in the molecular weight of PAX-2 and
PAX-6 with increasing levels of irradiation. In each case, limited change in molecular
dimensions occurred, up to a 10kGy dose of γ-radiation. At higher doses, however, there
was moderate to significant degradation occurred with increasing radiation dose.
Radiation-induced degradation in fabrics made from the lower-Tg PAX-6 material
increased at a greater rate than PAX-2 fabrics. A linear least-square fit of the inherent
viscosity data indicates nearly double the extent of degradation in PAX-6 compared to
PAX-2 with increasing irradiation, with decreases of 1.7% and 0.9% per kilogray,
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respectively. A 40% reduction in inherent viscosity and 17% reduction in Mw in the
PAX-6 fabric at 25kGy occured, compared to a 12% reduction in inherent viscosity and
20% reduction in Mw for PAX-2. These greater reductions were expected, based on the
higher sensitivity of the PAX-6 material. The higher sensitivity may be attributed to the
lower degree of crystallinity (measured in terms of ∆Hf) in PAX-6 relative to PAX-2.
The melting temperature of PAX-2 remained constant over the dose range. The
heat of fusion slightly decreased up to a dose of 20kGy, where there was a sudden 15%
increase and then a decrease to approximately the initial value. Unlike the linear PCL
electrospun fabric, increased levels of irradiation caused a decrease in the Whh, indicating
a narrower range in crystallite size. In this case, irradiation caused chain degradation of
the polyaxial PAX-2 fabric which, after a certain irradiation level, led to more
crystallizable chains with more uniform crystallite size.
PAX-6 electrospun fabric showed much less of a tendency to crystallize, as seen
by a 70% lower heat of fusion. The relatively large Whh shows the wide range of
crystallite sizes present in the microfibers. Over the range of irradiation doses, a steady
rise in the melting temperature of the electrospun fabric occured. Induced crystallization
occurred with increasing radiation levels up to 20kGy, where further increases in dosage
caused chain scission to pass beyond a critical level, thereby decreasing the material’s
ability to crystallize.
Another indicator of degradation, and perhaps more important for application, is
the effect of irradiation on burst strength of the electrospun fabrics. Burst strength is an
important parameter in fabrics, particularly the non-woven type, as it is a measure of the
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fabric’s ability to maintain functionality when deformed and stretched, as could be the
case in clinical application such as skin replacement. The effect of irradiation on burst
strength is illustrated by the data in Table 2.6. Higher dose levels caused a decrease in
the burst strength of the PAX-2 fabric, while 5- and 10kGy dose levels only reduced the
strength by 5% and 8%, respectively. Sterilization at 5kGy did not affect the ultimate
deflection of this material and even higher doses only caused minimal change in the
deflection characteristics. In the latter case, increased irradiation caused a slight increase
in brittleness of the elastoplastic material and a general weakening of the microfibers. A
greater change in the deflection characteristics may not have been seen as this parameter
is influenced by the conformation of the non-woven fabric and is not a test of individual
microfiber elongation. In contrast, the more radio-sensitive PAX-6 electrospun fabric
shows greater changes in burst performance due to irradiation. Irradiation at 5kGy
caused an increase in burst strength, with higher doses causing losses in strength. A
similar pattern was seen in the deflection at burst. This result is further evidence of
radiation-induced crystallization, as seen by DSC analysis. After an initial increase,
however, degradation of the material causes losses in strength and deflection. In both
PAX-2 and PAX-6, the 5kGy irradiation level did not result in noteworthy degradation of
the electrospun fabrics, as signified by less than 10% change in molecular dimensions.
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Table 2.6. Effect of irradiation on burst properties of electrospun fabrics prepared from
20 w/v% solutions. Reported as an average with one standard deviation.

Material

Irradiation
Level (kGy)

PAX-2

PAX-6

0
5
10
25
0
5
5
10
25

Ultimate Burst
Strength
(N/mm thickness)
34.4±1.8
32.8±2.4
31.5±1.9
22.5±0.4
66.0*
87.2*
94.8±4.1
75.7±4.3
73.6±19.3

Ultimate
Deflection (mm)
26.0±0.7
26.3±1.0
23.6±0.4
24.5±0.3
57.1*
73.6*
62.4±3.8
60.8±2.2
50.0±2.0

*Average of two specimens

2.4 Cytotoxicity of Electrospun PAX-2 and PAX-6 on L929 Mouse Fibroblasts
As shown in Figure 2.4a and 2.4b, cells exposed to Tyvek® stained red, indicating
cell viability. Cells exposed to copper wire did not stain, indicating cell death. Ideally,
one would hope that cells exposed to PAX-2 and PAX-6 would have the same reaction as
those exposed to the negative control. L929 mouse fibroblasts were exposed to PAX-2
and PAX-6 and stained to determine cell viability. Images from these samples are shown
in Figure 2.5. The images indicate PAX-2 had no detectable negative effect on cell
viability. PAX-6 elicited a very mild cytotoxic response, indicated by a relatively small
number of unstained cells. Qualitatively, PAX-2 and PAX-6 are comprised of the same
constituents, but the more absorbable PAX-6 could have released low-molecular weight
polymer or degradation products which can be responsible for the noted response.
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(a)
(b)
Figure 2.4. Cell viability of L929 mouse fibroblasts after exposure to (a) Negative control
(Tyvek®) and (b) Vehicle control (copper wire) after staining. Red-stained cells were
viable at the time of staining.

(a)
(b)
Figure 2.5. Cell viability of L929 mouse fibroblasts after exposure to (a) PAX-2
elecotrospun fabric and (b) PAX-6 electrospun fabric. Red-stained cells were viable at
the time of staining.

Conclusion
The chain configuration of linear and polyaxial polymers is relevant to the
physicochemical events encountered by the polymer solution during electrospinning and
radiation sterilization. PCL, PAX-2 and PAX-6 were electrospun without significantly
degrading the material. The thermal properties of the resulting constructs were
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dependant on the material and solution used. PAX-2 thermal properties changed based
on the fiber size, with larger fibers more closely mimicking the bulk material. Formation
of smaller microfibers forced crystallization in the linear material, but inhibited
crystallization in the polyaxial polymer. Less-volatile solvent compositions had little
effect on the chemical or thermal transitions of the resulting fabric, but could modulate
the physical characteristics.
Fabrics must be able to withstand standard sterilization conditions in order to be
used clinically. To study the effects of γ- and radiochemical sterilization, fabrics were
irradiated at various levels and changes in the physical/chemical characteristics
determined. It was shown that sterilization protocols involving low levels of irradiation
could be employed without significantly damaging the properties of electrospun
microfibers. The extent of fabric property (primarily thermal transitions and chemical)
degradation was shown to increase with the radiation dose.
Electrospun constructs created from PCL, PAX-2 and PAX-6 have been shown to
not harm cells, have fiber dimensions in the range of cellular structures, be semicrystalline in nature, be sterilized with no significant degradation, and provide an openpore morphology that could be suitable for cellular growth. As such, electrospun
constructs are potential candidates for the development of new wound dressings with
modulated physical/chemical conditions.
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CHAPTER 3
IN SITU FORMATION OF CONCENTRIC BICOMPONENT ABSORBABLE
MICROFIBERS BY ELECTROSPINNING

Introduction
Surface characteristics play a major role in the effectiveness of tissue engineering
scaffolds, wound covers and other biomedical devices. In the past, surface properties of
polymeric constructs have been limited to either the bulk characteristics of the construct
material or modification of the surface by coating or chemical/radiation treatments.
Previous studies focused on blended polymers have demonstrated the efficacy of
modulating the biodegradability in electrospun fabrics.1 Traditional absorbable polymers
such as polyglycolide, polylactide, and related copolymers are hydrophobic in nature.
Hydrophilic surfaces generally have higher cell affinity;2,3 to modify the surface
chemistry and topography of hydrophobic polymers, many techniques have been used,
including hydrochloric acid pretreatment4 and oxygen and argon plasma treatments.5,6
Electrospinning is a suitable means for producing compliant fabrics from
materials that are brittle or traditionally non-fiber forming. Poly(N-vinyl-2-pyrollidone)
(PVP) is a hydrophilic material that complexes with iodine and forms a commonly-used
topical antiseptic. Use of this product, however, is limited to topical application due to
the fact the product is a liquid and can be removed with a wipe or irrigation. Meanwhile,
PVP can be electrospun as a single-component system, but the result is a brittle, noncompliant fabric that has a cotton-like consistency. We hypothesized that combining
PVP with a thermoplastic absorbable polymer may produce a compliant fabric that can
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withstand the manipulation necessary for clinical use. Addition of iodine to this system
may in turn yield an antiseptic fabric which can be used in procedures where the liquid
version fails.
Polymethyl methacrylate (PMMA) is a material that has clinical use in bone
cements, among other biomedical devices; however, it is inherently brittle and has poor
fatigue strength. Past studies have shown that curing bone cement with a
polycaprolactone (PCL) component increases the flexural modulus and strength of the
cement.7 This addition seemed to have a positive influence only on the flexure
properties, however, and was detrimental to other strength components. In this case, the
low-Tg PCL could be viewed as a plasticizing agent. In order to improve the fatigue life
and maintain strength, PCL/PMMA fiber-reinforced composites may produce and exhibit
the improved flexural properties associated with the addition of PCL as well as the higher
strength properties possible with self-reinforced PMMA fiber cements. This fiber selfreinforcing technique has been studied previously and shown to improve tensile and
fracture properties of PMMA composites.8-10
Most of the electrospinning research to date has addressed single-component
systems, which presents a unique opportunity to study property modulation of
electrospun fibers produced from binary systems. The emphasis of this research has been
placed on the physical/chemical properties of fabrics made of bicomponent systems, with
particular interest in the characterization of their chemical isotropy and morphological
features. More specifically, the present segment of this research has been directed toward
further understanding the processing conditions that affect the physical/chemical
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properties of electrospun fabrics based on binary polymeric solutions. This research
pertains to the effect of polymer solution concentration and polymer type on the resulting
fabric morphology.
The first stage of this study was focused on determining the resulting morphology
of fabrics made from mixed polymer solutions. The second phase of the study was
geared toward controlling the fiber surface chemistry by modulating solvent and polymer
ratios in the spinning solution.

Materials and Methods
Poly(N-vinyl-2-pyrollidone) (PVP, Mw=55kDa) was purchased from Aldrich and
used as received. PVP is a material that has been used clinically for many years in
commercially-available products such as Betadine®. PAX-2, a crystalline, absorbable,
segmented copolyester, was produced at Poly-Med, Inc. and made by end-grafting llactide onto an amorphous polyaxial polymeric initiator, and used as a polyaxial
elastoplastic copolyester.11,12 Iodine was used as received from Aldrich as an additive to
spinning solutions containing PVP. Polymethyl methacrylate (PMMA, Mw=1,000kDa)
was purchased from Aldrich and used as received. Polycaprolactone (PCL, Dow
Chemical), a linear, crystalline “absorbable” polyester with a long history as a useful
biomedical material, was obtained for use.13,14
Solutions for electrospinning were made by dissolving the polymers of interest in
dichloromethane (DCM) and/or chloroform (CHCl3). Typical solutions were made from
15 to 30 w/v% polymer, with the polymer comprised of a mixture of two or more soluble
components. Fabrics were made from the above solutions by electrospinning under
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typical conditions as described in the “Materials and Methods” section in Chapter 2.
Microfiber composition and separation of its polymeric components were modulated by
varying solvent and polymer solution concentrations. Films were made from the same
solutions used for electrospinning and were generated by solvent casting a layer of
solution onto a surface. Once the solvent was volatilized, the resulting film was used for
analysis.
To analyze thermal transitions of films and microfiber specimens, differential
scanning calorimetry (DSC) analysis was performed using a Perkin-Elmer DSC-6. This
analysis was used to determine the effect of various solution compositions and
electrospinning parameters on the crystallinity of the resulting fabrics. Surface atomic
composition in the very outermost layer (about 5nm) was determined using a Kratos Axis
165 X-ray Photon Spectrograph (XPS). XPS was also applied to determine differences in
surface and bulk fiber composition. The differences were calculated by interpolating data
of carbon, oxygen, and nitrogen surface concentrations between the sample in question
and concentrations of the constituent materials. Surface composition was determined by
averaging the values obtained by interpolation and the significance of this data was
determined using a paired Student’s T-test. Other techniques such as attenuated total
reflectance Fourier-transform infrared analysis (ATR FT-IR) are not as precise for
analyzing the uppermost layers of a surface since they have resolution on the order of
several microns, which is on the same order of magnitude as the microfibers.
Accordingly, the ATR FT-IR results would more closely describe the bulk chemistry of
the microfibers rather than the surfaces, so differences between microfibers may be

69

overlooked. Thus, ATR FT-IR analysis was used to identify any correlation between
surface and bulk properties, up to several micrometers in depth. This analysis was
performed on a Perkin-Elmer Spectrum system with a universal ATR accessory.

Results and Discussion
3.1 Initial analysis and manipulation of bicomponent model systems produced from
PAX-2 and PVP

Initially, single component fabrics were produced from PAX-2 and PVP.
Microfibers were successfully collected, although the PVP fabric did not have good
handling properties, and the fabrics were analyzed for melting parameters (DSC) and
surface chemistry (XPS). PVP is a fully amorphous material, so a melting endotherm
was not observed. The DSC and XPS data are summarized in Table 3.1. XPS analysis of
PVP shows good correlation with the theoretical atomic concentrations, which are 75%C,
12.5%O and 12.5%N. These data were used to evaluate fabrics made from mixtures of
the two materials.

Table 3.1. DSC and XPS analysis on single-component electrospun fabrics made from
PAX-2 and PVP
Polymer
PAX-2
PVP

DSC
∆Hf
Tm(°C)
159
18.4
n/a
n/a

XPS Atomic Concentration
%C
%O
%N
65.2
34.8
0
74.5
12.0
13.6

To determine if phase separation naturally occurred from the two-component
solution, a film of approximately 1mm-thickness was made from an electrospinning
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solution containing 10 w/v% PAX2 and 13.3 w/v% PVP in 2:1 CHCl3:DCM. The film
had two distinct layers: a translucent top layer and a bottom cloudy and opaque white
layer. Samples from each layer were isolated for analysis by scraping a small amount of
the material of interest without penetrating the opposing layer. DSC and XPS analyses
were performed on both layers. DSC data (Figure 3.1) show very distinct thermograms;
the bottom layer had no defined melting peak and the top layer had a melting peak at
160°C with a heat of fusion of 21.4 J/g. Thermal analysis of the top layer exhibits the
same temperature profile seen in the PAX-2 polymer. XPS analysis of the bottom layer
shows atomic concentrations of 77.5%C, 12.6%O and 9.9%N; this result indicates that
the bottom layer is a combination of the PVP and PAX-2 polymers. This result also
explains the apparent contradiction between the thermogram of the bottom layer and the
cloudy, opaque nature of the layer. The solvent-cast thin film provides evidence of phase
separation between the two polymers with the top layer made of PAX-2 and the bottom
layer made of mostly PVP, but also shows that the separation is not complete. Some of
the PAX-2 material mixed with PVP, disrupting the crystallization of the PAX-2
material. These data do show the materials to be at least partially separated, so
electrospinning of the solutions could exhibit a phase-separated morphology. The
geometry of the microfibers, however, would cause the top layer seen in the film to
become the outer layer of the fiber, as the coordinate system for solvent evaporation
changes from orthogonal to cylindrical.
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(a)

(b)

Figure 3.1. DSC analysis from bottom and top layers of a solvent-cast film made from
PAX-2 and PVP showing distinct regions of crystallinity. (a) Bottom layer of film (b)
Top layer of film

With confirmation that solutions of PAX-2 and PVP exhibit phase separation,
another solution was made to attempt a reversal in top- and bottom-layer compositions.
It was postulated that the concentrations of polymers in solution and the relative
concentration of two solvents with different polarities, and hence different dielectric
constants, would determine surface migration of the different polymers. A solution was
prepared with 5 w/v% PAX-2 and 20 w/v% PVP with 3:2 CHCl3:DCM as a mixed
solvent. A thin film was cast as before, but the resulting layers were reversed, with the
translucent layer on the bottom and the cloudy white layer on top. DSC analysis was
performed on the different layers, as seen in Figure 3.2, and confirmed that the bottom
layer was made of PAX-2 and the top layer was mostly PVP with some PAX-2. When
translated to a cylindrical coordinate system, the outer layer would contain high levels of
PVP and the core would contain PAX-2. Once again, the PVP interfered with
crystallization of the PAX-2, which resulted in an unusual thermal profile. This analysis
demonstrates the feasibility of selecting the polymer that can migrate to the surface and

72

the manipulation of phase separation in films acts as a model for surface migration in
electrospun microfibers.

(a)

(b)

Figure 3.2. DSC analysis from bottom and top layers of a solvent-cast film made from
PAX-2 and PVP showing distinct regions of crystallinity. (a) Bottom layer of film (b)
Top layer of film

3.2 Analysis of bicomponent microfibers made from PAX-2 and PVP

To study the role that solution composition plays in controlling the surface
chemical composition of the resulting fabrics, five solutions were prepared from the
polymers PAX-2 and PVP in different combinations of the solvents DCM and CHCl3, as
outlined in Table 3.2. These fabrics represent (1) fairly equivalent polymer
concentrations with high concentration of CHCl3 in the solvent mixtures, (2) high
proportion of PVP in solution compared to PAX-2, (3) similarity to Fabric 2 but with
equal amounts of DCM and CHCl3 solvents and the inclusion of iodine to complex with
the PVP, (4) high concentration of PVP relative to PAX-2 with iodine included to
complex with PVP, and (5) similarity to Fabric 1 but with the inclusion of iodine. The
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fabrics were successfully electrospun and analyzed for their thermal properties by DSC,
surface atomic composition by XPS, and chemical group frequencies by ATR FT-IR.

Table 3.2. Compositions of five bicomponent solutions of PAX-2 and PVP and two
single-component solutions of the two polymers used as controls
Fabric

Polymer

Control 1
Control 2

PAX-2
PVP
PAX-2
PVP
PAX-2
PVP
PAX-2
PVP
Iodine
PAX-2
PVP
Iodine
PAX-2
PVP
Iodine

1
2
3

4

5

%DCM / %CHCl3
in solution
100 / 0
50 / 50
33 / 67
40 / 60
50 / 50

50 / 50

33 / 67

% Polymer in
Solution
20
25
10
13.3
5
20
5
20
0.5
4.4
15.8
0.2
10
13.3
0.1

Thermal data was used to assess the degree to which mixing interfered with
crystallite formation. If the materials mix on a molecular level, the non-crystalline PVP
may inhibit crystallite formation in the partially-crystalline PAX-2. The amount of
inhibition was determined by the deviation from the expected heat of fusion (based on
relative concentration of PAX-2 in the microfiber to the heat of fusion in a fiber
comprised only of PAX-2). This value was calculated as a simple ratio. The results of
these tests are shown in Table 3.3. All theoretical values of ∆Hf were higher than the
actual values, but some fabrics exhibited larger variations than others. In fabrics
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prepared with higher concentrations of PAX-2 (Fabrics 1 and 5), the data indicate some
inhibition of crystalline formation which resulted in a decreased heat of fusion. Other
fabrics showed only slight variations from the theoretical, indicating a lesser degree of
inhibition.

Table 3.3. Thermal changes in electrospun microfibers due to the presence of PVP
Fabric

Polymer

Control 1
Control 2

PAX-2
PVP
PAX-2
PVP
PAX-2
PVP
PAX-2
PVP
Iodine
PAX-2
PVP
Iodine
PAX-2
PVP
Iodine

1
2
3

4

5

% Polymer
in Solution
20
25
10
13.3
5
20
5
20
0.5
4.4
15.8
0.2
10
13.3
0.1

Tm
∆Hf (J/g)
(°C) Theoretical
Actual
159
n/a
18.4
n/a
157

7.9

6.4

158

3.7

3.6

161

3.6

3.5

160

4.0

2.1

159

7.9

6.6

ATR FT-IR data were analyzed for the presence of an ester peak (indicating
PAX-2, found at about 1740cm-1) and/or an amide peak (indicating PVP, found at about
1650cm-1) and normalized with the CH peak, found at 1458cm-1. To determine the
presence of a constituent material, the normalized heights for the ester and amide peaks
were compared to the peak height of the control polymer. These data are summarized in
Table 3.4. By comparing the height of the ester and amide peaks, the amounts of the
constituent polymers can be calculated. The data show good correlation with the
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composition of the bulk fabric, but the analysis is not surface-sensitive enough to show
any phase-separated nature of the microfibers.

Table 3.4. ATR FT-IR data of fabrics made from PAX-2 and/or PVP

Fabric

Polymer

Concentration
in Fabric (%)

Control 1
Control 2

PAX-2
PVP
PAX-2
PVP
PAX-2
PVP
Iodine
PAX-2
PVP
Iodine
PAX-2
PVP
Iodine

100
100
42.9
57.1
19.6
78.4
2.0
21.6
77.5
1.0
42.5
56.6
0.9

1
3

4

5

Normalized
Component(s)
Peak Height
Present
Ester Amide
3.29
0
PAX-2
0
3.19
PVP
32.5% PAX-2
1.70
3.43
67.5% PVP
0.91

2.94

23.1% PAX-2
76.9% PVP

0.85

3.00

21.5% PAX-2
78.5% PVP

2.18

2.34

47.4% PAX-2
52.6% PVP

Microfiber surface chemistry was used to determine the extent of selective
polymer surface migration based on the solution parameters. The results, shown in Table
3.5, describe a surface that can be modulated by changing the composition of the
electrospinning solution. Surface constituents were calculated by interpolation of data
collected from the control fabrics. Interpolated data based on each component yielded
different results, so surface components are presented as an average and standard
deviation of the three interpolations. Fabric 1 has a surface composition that is very
different from the bulk composition of the microfiber. The bulk fiber contains 43%
PAX-2, but XPS analysis shows twice this amount on the surface of the fiber. Similarly,
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Fabrics 3 and 5 show much higher concentrations of PAX-2 on the surface than in the
bulk fabric. Fabrics 2 and 4 show some differences between the surface and bulk
compositions, but not to the degree seen in the other fabrics.

Table 3.5. Surface chemistry of bicomponent electrospun fabrics and single component
control fabrics made from PAX-2 and/or PVP. Surface components reported as an
average and one standard deviation.

Fabric

Polymer

Control 1
Control 2

PAX-2
PVP
PAX-2

1
2
3

4

5

PVP
PAX-2
PVP
PAX-2
PVP
Iodine
PAX-2
PVP
Iodine
PAX-2
PVP
Iodine

%DCM /
%CHCl3
in solution
100 / 0
50 / 50
33 / 67
40 / 60
50 / 50

50 / 50

33 / 67

% Polymer
in Solution
(in Fabric)
20 (100)
25 (100)
10 (42.9)
13.3 (57.1)
5 (20)
20 (80)
5 (19.6)
20 (78.4)
0.5 (2.0)
4.4 (21.6)
15.8 (77.5)
0.2 (1.0)
10 (42.5)
13.3 (56.6)
0.1 (0.9)

XPS atomic
concentration
%C %O %N
65.2 34.8
0
74.5 12.0 13.6

Component(s)
on Surface
PAX-2
PVP
86±10% PAX2
14±10% PVP
28±6% PAX-2
72±6% PVP

67.5 31.9

0.7

72.5 18.5

9.0

69.0 27.6

3.4

68±8% PAX-2
32±8% PVP

76.6 19.4

4.0

27±47% PAX2
73±47% PVP

65.1 33.7

1.2

96±5% PAX-2
4±5% PVP

The use of iodine was intended to change the dielectric constant and solubility of
PVP by partial complexation with its chain side groups. The yellow color of the iodine
complex was used as a marker. The addition of iodine to the electrospinning solution
resulted in an increase of PAX-2 on the microfiber surface (Fabric 1 v/s Fabric 5); a
paired Student’s T-test revealed that this increase had a statistical significance of 93%.
The iodine complexes with PVP, increasing the solubility of the PVP component and
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causing it to remain dissolved in solution longer, moving more of the PVP to the fiber
core and increasing the concentration of PAX-6 on the fiber surface. The retention of
increased PVP in the fabric core resulted in a decrease in the phase mixing seen in Fabric
1. Indeed, DSC data demonstrate decreased phase mixing as the actual heat of fusion
approaches the theoretical value. These results suggest that changes in the solubility of
the components can be responsible for changes in the surface composition of electrospun
microfibers.
Differences between Fabrics 2 and 3 can be attributed partially to the addition of
iodine to the electrospinning solution, but differences in solvent enhance this effect. In
Fabric 2, the concentration of PAX-2 on the microfiber surface was close to that of the
bulk material, but the difference in solution composition in Fabric 3 produced an increase
in the PAX-2 surface concentration. The PAX-2 material was less soluble than PVP in
DCM; in solutions with increased DCM, the PAX-2 will precipitate from solution faster
to form a PAX-2-rich microfiber sheath.
Another dimension in the modulation of surface composition is the concentration
of individual polymers in solution. The impact of polymer concentration is evidenced in
the analyses of Fabrics 3 and 4. Fabric 3 contains four times as much PVP as PAX-2,
whereas Fabric 4 contains only 3.6 times as much PVP as PAX-2.
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3.3 Analysis of bicomponent microfibers made from polycaprolactone and polymethyl
methacrylate

In order to plasticize bone cement to improve its flexural and fatigue properties,
PCL microfibers can be infused in PMMA cement. For this technique to be effective,
electrospun microfibers containing PCL and PMMA should be designed with high
concentrations of PMMA on the surface to interact with methyl methacrylate monomer
and PCL mostly contained in the core of the microfibers to serve as a toughening fiber
reinforcement. Partial mixing of the two components can lead to good adhesion between
PCL and PMMA; however, complete mixing can interrupt the crystallization of PCL and
inhibit its ability to plasticize the cement. Bicomponent microfibers were prepared from
PCL and PMMA, as shown in Table 3.6, to determine a solution composition that would
yield microfibers with good crystallite formation (as determined by DSC) and a PMMArich surface.

Table 3.6. Compositions of bicomponent solutions of PCL and/or PMMA used to
produce electrospun microfibers
Fabric

Polymer

Control 1
Control 2

PCL
PMMA
PCL
PMMA
PCL
PMMA
PCL
PMMA
PCL
PMMA

1
2
3
4

%DCM / %CHCl3
in solution
100 / 0
20 / 80
50 / 50
50 / 50
33 / 67
67 / 33
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% Polymer in
Solution
20
20
14
6
10
10
10
10
10
10

The fabrics were analyzed for thermal transition to determine the effect PMMA
has on the crystallization of PCL during the electrospinning process (Table 3.7). In all
cases except the Fabric 2 analysis, the actual ∆Hf value was greater than the calculated
theoretical value. These results might indicate that electrospinning of these solutions
created an environment where PCL was able to crystallize to a greater degree than in a
fabric made from only PCL. The PMMA component did not interfere with the
crystallization of the PCL, which could indicate good phase separation of the materials.
In Fabrics 3 and 4, measured values of Whh were smaller than in the single-component
PCL fabric. This result could be due to the decrease in the ∆Hf, but could also indicate a
more uniform crystallite size distribution. Fabrics 1 and 2 exhibited increases in the Whh
that may be a sign of increased crystallite size distribution, especially in Fabric 2.
Thermal data for Fabric 2 indicate a greater degree of phase mixing between PCL and
PMMA than any other experimental fabric in Table 3.7.

Table 3.7. DSC analysis of bicomponent fabrics produced from PCL and PMMA
Fabric

Polymer

Control 1
Control 2

PCL
PMMA
PCL
PMMA
PCL
PMMA
PCL
PMMA
PCL
PMMA

1
2
3
4

% Polymer
in Solution
20
20
14
6
10
10
10
10
10
10

Tm
∆Hf (J/g)
(°C) Theoretical Actual
58
n/a
54.5
n/a

80

Whh
(°C)
5.9

61

38.2

47.4

8.8

60

27.3

26

9.9

57

27.3

33.9

5.2

57

27.3

39.2

4.7

Conclusions
Bicomponent fabrics were prepared from combinations of several polymer
systems with possible clinical relevance. Initial testing on films indicated that phase
separation did occur between PAX-2 and PVP and could be modulated by controlling the
solution composition, especially the relative polymer concentration and solvent ratio.
This result was confirmed by XPS analysis performed on electrospun bicomponent
microfibers made from a single solution containing PAX-2 and PVP. Rapid
solidification during fiber formation does not allow the complete phase separation seen in
the films, however. Similarly, fibers created from solutions with PMMA and PCL also
exhibited phase separation.
The ability to produce electrospun fibers containing two materials, using one
solution, ensures a uniform distribution of material in the resulting fabric. Additionally,
the separation of components allows the materials to retain their individual
characteristics. The phase separation can be manipulated to provide a specific surface
chemistry or to facilitate the spinning of a compliant fabric from difficult-to-process
materials. It may also be possible to control the distribution of one or more bioactive
agents for controlled release applications, as in the case of tissue growth promoters.
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CHAPTER 4
ELECTROSPINNING OF SOLID MICRODISPERSIONS IN POLYMER SOLUTION
AND PROPERTIES OF RESULTING MICROFABRICS

Introduction
The electrospinning process represents a possible solution to many problems in
biomedical design, and as such has gained much attention in recent years. Some
materials of biomedical significance, such as PMMA, are inherently brittle which, in
clinical conditions, can lead to stress cracking and failure in implanted devices.1-3 The
use of fiber-based reinforcement has been shown to improve the flexural modulus,
breaking strength, ductility and other mechanical properties of these materials.4 In some
biomedical applications, it is advantageous to include organic or inorganic particles to
improve the clinical performance of the device. Barium sulfate has been incorporated as
a radiopacifier in methacrylate bone cements, hydroxyapatite or calcium carbonate has
been incorporated in absorbable polymers for bone regeneration applications, and silver
has been included in fibers to produce inherently antimicrobial fabrics.5-7 Antimicrobial
fabrics are of interest for use in wound dressings. These types of included particulate,
however, have a tendency to agglomerate in continuous polymeric matrices, which
causes defects in the material matrix and leads to high stress concentrations that
adversely affect the strength of composites.8
Encapsulation of barium sulfate with PMMA can increase the fatigue properties
of bone cement.9 It is hypothesized that the encapsulation of barium sulfate in
electrospun PMMA microfibers could improve the strength and fatigue properties of
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bone cement. PMMA and polycaprolactone (PCL) composite fibers, for example, could
be used to encapsulate barium sulfate. The use of PCL was previously studied in bead
mixtures and shown to be effective in increasing flexural strength.10 In those particular
studies, PMMA/PCL beads of about 60µm were produced by suspension polymerization
of MMA monomer with dissolved PCL. Bone cements made with a portion of these
beads had an increase of approximately 19% in flexural strength but also had a 16%
decrease in compressive yield strength. Together, encapsulation of the radiopacifier and
the addition of fiber reinforcement could cause decreased stresses at the implant-bone
interface as well as decreased bone resorption.11
It is not only bone cements that may benefit from particulate-encapsulated
electrospun fabrics. Poly-Med, Inc.’s unique position and broad catalogue of
biomedically-relevant polymer systems provide opportunity to explore several
microfiber/particulate systems with possible clinical importance. One such polymer class
includes the PAX materials. An electrospun system combining PAX with phosphate
glass particulates could be used in orthopedic devices implanted in areas where healing is
improved with the availability of calcium and phosphate ions. Calcium phosphate
ceramics have been shown to be osteoconductive,12-14 which creates an opportunity for
their use in these electrospun scaffolds. Similarly, hydroxyapatite is another
osteoconductive material already in wide clinical use15,16 that can be dispersed in the
PAX system for use in orthopedic devices. In a different type of application,
polyglycolide (PGA) microspheres could be included in PAX fibers. PGA microspheres
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could be further modified with ionically bound surface-immobilized basic drugs,17
creating a unique and tailorable drug-delivery system.
The initial stage of this study was to determine the key aspects of solution
preparation for the manufacture of evenly dispersed particulate. Once this step was
accomplished, the goal was to apply the knowledge to the production of the clinically
relevant systems discussed above.

Materials and Methods
To explore the dispersion of microparticles in electrospun fabrics, two model
systems were used comprising (1) a high molecular weight linear non-absorbable
polymer and (2) an elastoplastic copolyester. The former model system, poly(methyl
methacrylate) (PMMA, Mw = 996,000), was obtained from Aldrich and used as received.
PAX-6, a crystalline, absorbable, segmented copolyester, was manufactured at Poly-Med,
Inc. and made by end-grafting l-lactide onto an amorphous polyaxial polymeric initiator,
and used as a model polyaxial elastoplastic copolyester.18,19 Polycaprolactone (PCL,
Dow Chemical) was used as a polymeric plasticizer in PMMA electrospun microfibers.
Both PMMA and PCL have been used in medical devices in the past.20-22
Dichloromethane (DCM) and chloroform (CHCl3) were obtained from Aldrich and used
as solvents without further purification.
Barium sulfate (BaSO4) and hydroxyapatite (HAP) were purchased from Aldrich
as fine powder and further processed to reduce particle size. Phosphate glass, an
absorbable bioactive glass, was prepared at Poly-Med, Inc. as described previously.23
Similarly, PGA microspheres were produced at Poly-Med, Inc. and used as acid-
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terminated microporous microparticles.24 Several additives were used to prevent
agglomeration of particles in the spinning solution and resulting microfibers. These
additives include acetone and the non-ionic surfactant TWEEN® 80, both of which were
purchased from Aldrich and used as received.
To obtain small-diameter particulates for use in electrospinning, as-received and
in-house materials had to be further processed. First, the powders were cryogenically
milled in a SPEX-6850 freezer/mill. The freeze-milled particles were then filtered
through a 5µm sieve in an isopropyl alcohol mobile phase with the assistance of a
sonicating probe. The collected filtrate was dried under vacuum and classified as a
maximum of 5µm in diameter.
Electrospinning solutions were prepared by first dissolving the polymeric matrix
in most of the solvent. The remainder of solvent, typically about 1/3 total solvent
volume, was mixed in a separate jar with the particulates and dispersants (if so needed).
The jar containing the solvent and polymer matrix solution was placed on a roller until a
homogenous dispersion was formed. The jar containing particulates was agitated by
sonication for no less than one hour to break apart any agglomerated particulates and to
allow the dispersant to “coat” all particles. Once separate jars were prepared, the jar
containing the particulate was added to the jar with the dissolved polymer matrix. This
mix was shaken until a homogenous dispersion was formed. Immediately, this dispersion
was transferred into a syringe for electrospinning under typical conditions on a custom
electrospinning apparatus constructed in-house, as described in the “Materials and
Methods” section of Chapter 2. If solution went unused for an extended period,
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particulates would settle and possibly agglomerate as the dispersant was diluted by the
additional volume of the total solution.
Electrospun microfibrous fabrics were analyzed to determine (1) the effect of
particulate on the chemical/physical properties of various fabrics, (2) loading
concentration of particulate in the polymer matrix and (3) the homogeneity of particulate
dispersion. To study effects on chemical/physical properties, thermal properties were
determined by DSC analysis on a Perkin-Elmer DSC-6. The concentration of the
insoluble dispersed phase was determined by thermolysis for inorganic materials with a
high degradation temperature. Thermolysis was accomplished by heating electrospun
fabrics at 500˚C for 2 hours and obtaining the weight percent remaining. The polymer
fully degrades at this temperature, leaving only residual particulates. Dissolution for
removal of the soluble polymer matrix and nitrogen analysis was employed to pinpoint
nitrogen-containing particulate in matrices containing nitrogen in the polymer chains. A
Hitachi S3500-N SEM system with YAG backscattering detector was used to visualize
the dispersion of particulate in electrospun microfibers. Diameters were determined by
measuring at least 20 random samples on SEM images; results were reported as an
average with one standard deviation. The differences were detected by the appearance of
bright spots in the microfibers, indicating spectral differences in material with
significantly different chemistries.
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Results and Discussion
4.1 Establishment of solution/mixing conditions to produce uniform dispersion

Initially, PMMA was used as a model carrier for dispersed BaSO4 particles. The
first trials attempting to produce electrospun microdispersions did not employ any means
of dispersing or de-agglomerating the added BaSO4. This technique produced fibers with
non-uniform diameter and particulate dispersions, as shown in Figure 4.1. One purpose
of producing microdispersions is to have an even dispersion with very little clumping of
particulates; this technique of dispersion preparation did not produce the desired results.

Agglomerated
BaSO4

Figure 4.1. SEM image of PMMA electrospun microfibers with 10% unevenly dispersed
BaSO4
The next technique used to produce particulate-bearing electrospun microfibers
involved soaking the particles in a separate solvent. The BaSO4 was sonicated in acetone
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to promote acetone adsorption onto the polar inorganic material and effectively form an
acetone-rich film around each particle of BaSO4, as well as to supply enough energy to
break apart any agglomeration in solution. When mixed with the PMMA solution, the
goal was to maintain the acetone-rich sheath around the BaSO4, preventing clumping for
a short period of time. Figure 4.2 shows the results of this technique’s application to a
solution comprised of 19.1 w/v% PMMA in solution with 9 v/v% acetone. The final
fabric was designed to theoretically contain 10 w/w% BaSO4. The acetone did seem to
be effective in retaining a rich film around the particulates, but also caused a local
thickening of the spinning solution, creating regions of higher polymer concentration.
The PMMA has low solubility in acetone compared to methylene chloride or chloroform,
which caused an increase in viscosity around the particulates and lead to locally largerdiameter microfibers. Physically, this method resulted in modified “string-of-pearls”
electrospun fibers with each pearl containing the BaSO4 particles. The pearl-like features
were much larger than the fibers and were not on the small scale that makes electrospun
fabrics so attractive. SEM analysis showed a fiber diameter of 3.0±1.7µm fiber diameter
with “pearl” dimensions of 83.9±15.1µm length and 38.4±8.7µm diameter. Thermolysis
analysis did show good conversion from the prepared solution to final fabric, meaning the
particulate remained mixed in solution during the electrospinning process and did not
settle in the syringe, the latter which could lead to significantly lower particulate
concentration in the fabric than in solution.
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(a)

(b)

Figure 4.2. 10% BaSO4 dispersed in PMMA, electrospun from 20 w/v% solution
with acetone as anti-agglomerant, (a) 500µm scale bar and (b) 100µm scale bar

In order to form uniformly-sized microfibers, another method was employed to
disperse the particulates. Surfactants have been used in the past to assist in maintaining
deagglomerated micro-/nanoparticles in polymer solutions25 and TWEEN® 80 is a
surfactant that is commonly used in food and medical products.26 This surfactant was
selected for use in this study as a means to create uniform particle dispersions in
electrospun fibers. When used in this application, particle dispersion in the final
electrospun fabric was shown to be much more uniform, as shown in Figure 4.3. SEM
analysis showed uniform fibers with an average diameter of 6.0±1.0µm. Based on the
SEM data, the surfactant treatment showed efficacy as a method of dispersing the
particulate. Thermolysis showed 9.6 w/w% BaSO4 in the final fabric, which correlates
with the theoretical loading of 10%.

Figure 4.3. 10% BaSO4 dispersed in PMMA, electrospun from 20 w/v% solution with
TWEEN® 80 as anti-agglomerant.
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With a method in place for uniformly dispersing particulates in electrospun
microfibers of consistent size, it was of interest to know the extent to which the
microfibers could be loaded. To this end, a highly-loaded fabric was defined as
containing approximately 50 wt% insoluble microparticles. A solution was prepared in
two parts, with Part A containing 6 grams PMMA, 10mL DCM and 10mL CHCl3 and
Part B containing 750mg BaSO4, 130mg TWEEN® 80 and 10mL CHCl3. The parts were
prepared and combined as described above. From the resultant dispersion, an electrospun
fabric was successfully prepared with a theoretical particulate loading of 50%.
Thermolysis showed a BaSO4 concentration of 54.3 w/w% in the final fabric. This high
loading shows the large range in which PMMA fibers could be loaded. The fiber was
produced from 20 w/v% solution of PMMA, so it appears that as long as there is enough
fiber-forming material present then electrospun fibers can be produced, even with high
particulate loading concentrations.

4.2 Application of dispersion techniques to various particulates/matrix systems

Techniques have been established for preparation of electrospun PMMA
microfibers with uniformly dispersed BaSO4 particulates. As discussed above, there are a
host of possible composite particulate/matrix systems that could be produced by taking
advantage of these techniques to prepare unique electrospun fabrics. In order to
investigate the application of these techniques on systems with different properties than
those of PMMA and BaSO4, several fabrics were prepared using the absorbable PAX
polymer system as well as the PMMA system with various loading materials, as
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described in Table 4.1. These fabrics represent a wide range of properties and potential
applications.

Table 4.1 Particulate-loaded electrospun fabrics with PAX-6 and PMMA used as fiber
matrix.
Microfiber
Matrix Material

Particulate
Material

PMMA
PAX-6

HAP
HAP
Phosphate
Glass

PAX-6
PAX-6
Fabric A
Fabric B

Theoretical
Loading
Concentration (%)
11
11

PGA

3.7
3
9

Fabrics from Table 4.1 were produced under the same conditions developed for
the preparation of PMMA/BaSO4 composites. SEM images of several of these fibers can
be seen in Figure 4.4. The average fiber diameter for the PMMA fabric containing HAP,
seen in Figures 4.4(a) and 4.4(b), was 6.1±1.8µm, which is very similar to the diameters
in the PMMA/BaSO4 fabric with similar loading. Thermolysis showed 9.2 w/w% HA in
the electrospun fabric, which was also similar to the conversion seen in the model
PMMA system. The concentration of the insoluble dispersed phase as determined by
solubilizing and removing PMMA matrix was 8.6 w/w%, which is comparable to the
results obtained with thermolysis. This data indicates that the type of insoluble material
does not affect the spinning properties of the solution.
PAX-6 was electrospun with HAP using the same solution preparation techniques
as above. The solution contained 20w/v% PAX-6 and was designed to have a HAP
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concentration of 11w/w% in the final electrospun fabric. Electrospinning produced the
fabric seen in Figures 4.4(d) and 4.4(e), as analyzed by SEM analysis. The resulting
fabric had an average diameter of 11.3±4.1µm. This diameter is larger than expected and
may be attributed to the mass of material that is contained in the microfibers. In contrast,
solutions with a concentration of 20 w/v%, PAX fabrics have been shown to have fiber
diameters of approximately 7µm. Increasing the concentration of the non-volatile
materials by 10%, while maintaining a constant electric field, would result in larger
diameter fibers due to the increase in gravitational force while retaining similar
“orientation” forces caused by the electric field. As the solvents volatilize, a greater
amount of material is present in a more viscous solution, so the chaotic whipping motion
may be dampened, forming larger-than expected fibers. It stands to reason that solutions
made with lower concentrations of particulate would yield smaller-diameter fibers. A
solution containing 15 w/v% PAX-6 with a final theoretical loading of 3.7 w/w%
phosphate glass was made with TWEEN® 80 used as a dispersant. Thermolysis showed
a sample of the fabric to contain 2.2 w/w% phosphate glass. This low concentration of
particulate did not significantly affect the diameter of the fiber. This fabric, shown in
Figures 4.4(e) and 4.4(f), had an average diameter of 4.5±1.7µm. With a slightly lower
polymer concentration in solution and a much lower particulate concentration, the fibers
approached those seen in PAX fibers of similar concentration without added particulate.
It appeared that microfibers containing less particulates had smaller average diameters
when compared to those which contained more phosphate glass. This distribution
resulted in the relatively high standard deviation in fiber diameter.
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PGA microparticles with ionically immobilized chlorhexidine were tested for
their suitability for incorporation in electrospun microfibers. Electrospun fabric was
successfully prepared with 9 w/w% microbeads in a 20 w/v% solution of PAX-6. The
microbeads contained 1.2% drug, as determined by bulk N2 analysis. Chlorhexidine is an
antiseptic drug that is commonly used in dental mouthwash for gingivitis, but is also used
in topical wipes for cleaning wounds or before surgery.27
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(a)

(b)

(c)

(d)

(e)

(f)

Figure 4.4. Particulate-loaded electrospun fabrics comprised of (a) & (b) 11% HAP in
PMMA, (c) & (d) 11% HAP in PAX-6 and (e) & (f) 3.7% phosphate glass in PAX-6.
The scale bar in images (a), (c) and (d) is 500µm and the scale bar in images (b), (d) and
(f) is 100µm. SEM analysis was performed on a Hitachi S3500-N SEM system with
YAG backscattering detector.
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Conclusions
A method for the preparation of electrospun PMMA microfibers with uniformly
dispersed (without agglomeration) BaSO4 was developed. This method was used to
successfully produce microfibers with up to 55 w/w% BaSO4. The techniques were then
successfully applied to various polymer / particulate systems with different properties and
intended uses. Increasing the loading of the particulates in the electrospun microfibers
caused a general increase in fiber diameter. This increase was a consequence of the
increased non-volatile concentration and did not seem related to the type of insoluble
material in the spinning solution. These methods can be applied to a variety of systems,
with organic or inorganic particulate and absorbable and/or non-absorbable materials.
Applications for this technology include fiber reinforcements for composites, dispersion
and encapsulation of small insoluble particulate, and for inclusion of insoluble active
agents to a continuous fiber matrix. Of the many potential applications of the instant
technology, the use of immobilized antiseptic agents on absorbable microparticulate and
the incorporation of microparticulate phosphate glasses for promoting bone regeneration
are most interesting clinically.
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CHAPTER 5
EFFECT OF DRUG STRUCTURE ON ITS RELEASE FROM ABSORBABLE
ELECTROSPUN MICROFIBERS

Introduction
Seen as a novelty from its discovery until the late 1990s, electrospinning has
recently come to the forefront of biomedical research for its possible application to tissue
scaffolding, wound dressings, or a myriad of other devices. A major benefit of using
electrospun non-woven fabric is the ability to tailor the material for specific needs. The
electrospinning process has been used to produce fabrics from certain traditional fiberforming materials, as well as materials that do not have surface energies capable of
conventional fiber-production protocols. Additionally, the electrospinning solution can
be modified to accommodate soluble or insoluble additives to further modulate the
material and performance-related properties of the resulting fabric. The process does not
necessitate the use of elevated temperatures and, as such, can accommodate heatsensitive materials with little to no adverse effects on their performance, as long as the
additives are stable in solution.
The addition of active components to electrospun materials increases their
viability as a biomedical device. Several drugs have been incorporated in electrospun
scaffolds, including itraconazole,1 paclitaxel,2 cefazolin,3 and mefoxin4. These drugs
were chosen based on the proposed use of the scaffold and studied for the particular
release kinetics of the specific drug/scaffold system. Little work has been done to
understand the cause of differences in the release profiles of these drugs from electrospun
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fibers with extremely high surface-to-volume ratio. One study showed that release
kinetics vary in electrospun fabrics based on the compatibility of the drug in the
polymeric matrix.5 Specifically, two soluble drugs were shown to have a zero-order
release from electrospun polylactide (based on the degradation rate of the polymer
matrix) while an insoluble drug migrated to the surface during fabric preparation and had
a release profile entailing an early drug burst. Complicating factors of the
electrospinning process include solvent evaporation and high voltage potentials, the latter
which create a very complex environment that could cause migration of a particular drug
to the fiber surface or binding of the drug to the polymeric chains. Drug release has
shown dependence on chemical structure in other studies,6 but these studies have not
explored the role of the general drug chemical properties on their release.
The ability to modulate drug release profiles from medical constructs of the same
material is another area of interest. Traditionally, to modulate the release of drug from a
construct, some changes in device composition had to be made. The modulation may
target the polymeric material containing the drug,7-10 e.g. heat treatments to control the
polymorphic configuration of the matrix,9 light-mediated binding of drugs,11 and other
methods. The effect of radiation on drug release rate has yielded mixed results. In some
cases, sterilization with gamma radiation has no effect,12-14 while sterilization with
25kGy γ-radiation has shown effects in other studies. In one case, poly(d,l-lactide-coglycolide) microspheres showed slight changes in thermal properties and an increase in
burst effect while releasing insulin-like growth factor-I (IGF-I).15 In general, however,
gamma sterilization has shown minimal effect on the release kinetics.
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Accordingly, the present study focuses on determining the release of model low
molecular weight drugs that are acidic (naproxen), basic (proxyphylline), neutral
(acetaminophen), and phenolic (triclosan) to establish the effect of drug chemistry on
release kinetics. Chemical composition and drug structure of these materials are more
completely described in Table 5.1. Solubility is one factor expected to have an impact on
the release rate of each drug, so it is expected that Proxyphylline will show a greater
release than any of the other drugs and Triclosan to show a relatively slow release. Each
of the drugs used in this study has medical application. Naproxen is a widely used nonsteroidal anti-inflammatory (NSAID), an over-the-counter medication, that has been
shown to reduce post-surgical adhesions when administered orally.16,17 As part of an
electrospun fabric system, this drug could be used in a surgical gauze to reduce
inflammation and post-surgical adhesions. Proxyphylline is a vasodilator and is a moresoluble derivative of theophylline.17 When incorporated in an electrospun fabric, this
drug could be employed percutaneously as a blood vessel wrap for treating
atherosclerosis. The drug acetaminophen is a commonly used antipyretic/analgesic
compound; its primary purpose is fever reduction and pain relief by modifying the body’s
response to pain and causing the hypothalamus to lower body temperature.17 Triclosan is
a widely used antiseptic and disinfecting agent which is currently found in soaps,
toothpastes, trash bags and many other commonly-used consumer goods.17 In Coated
VICRYL® Plus Antibacterial suture, the presence of triclosan is associated with a
reduction in inflammation and inhibition of bacterial colonization.18,19 As part of an
adhesion prevention barrier, triclosan could act as local antibacterial, antiseptic and
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disinfectant gauze, hence our interest in this drug. The drugs used in our studies were
also selected to meet certain physicochemical criteria that were postulated to affect their
release profile from the electrospun microfibers. These criteria are associated with the
drugs described in Table 5.1 and include (a) pKa associated with the display of acidic,
basic, or neutral properties, (b) solubility, and to a lesser extent (c) molecular weight.
Initially, our study dealt with the preparation of drug-loaded fabrics. Once drugloaded fabrics were obtained, batch release studies were performed to determine the
release properties of the selected drugs from non-woven electrospun fabrics. Lastly, the
effect of radiation sterilization on the drug release profile of each drug/microfiber system
was studied.
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Table 5.1. Chemical information for drugs used in the present study

Drug

MW
(atomic
Chemical
mass
Composition
unit)

Structure

pKa-Related
Properties

Water
Solubility
@ 20˚C

Naproxen
230.3

Acidic

Slightly
soluble

Proxyphylline

C10H14N4O3

238.2

Basic

Very
soluble

Acetaminophen

C8H9NO2

151.2

Weakly Acidic

Slightly
soluble

Triclosan

C12H7Cl3O2

289.5

Weakly Acidic

Very low
solubility
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C14H14O3
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Materials and Methods
PAX-6, a crystalline, absorbable, segmented polyaxial copolyester, was
manufactured at Poly-Med, Inc. by end-grafting 10/1 l-lactide/ε-caprolactone onto an
amorphous polyaxial polymeric initiator comprised of 6.5/6.5/1 εcaprolactone/trimethylene carbonate/glycolide, and used as an polyaxial elastoplastic
copolyester.20,21 Acetaminophen, naproxen, proxyphylline and triclosan were purchased
from Aldrich and used as received.
Electrospinning solutions were prepared from 16.7 w/v% polymer with 1:1.5
dichloromethane (DCM):chloroform (CHCl3) by rolling components on a jar roller at
room temperature until dissolved. Drugs were added to solution to produce a final drug
loading of 3 w/w%. The fabrics were prepared under typical conditions on an in-house
constructed electrospinning apparatus as described in the “Materials and Methods”
section of Chapter 2.
In order to test the effect of sterilization on the drug release profile of electrospun
constructs, samples of fabrics were subjected to several sterilization protocols. Samples
measuring 2" x 2" were hermetically sealed in individual foil pouches in an inert
atmosphere. Sealed samples were γ-sterilized at 25kGy or radiochemically sterilized at 5
or 10kGy in the presence of a radiochemically-generated formaldehyde gas.
To test the fabrics for drug release rate, approximately 100mg of each fabric per
specimen were placed in 25mL of 7.2pH 100mM phosphate buffered solution and
maintained at 37˚C to simulate physiological conditions. Samples (50µL each) were
taken at appropriate time points and analyzed by HPLC for drug concentration. Data
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from each specimen were compiled to form a release profile for each drug from the PAX6 electrospun fabric. To ascertain the effectiveness of drug release, electrospun fabrics
containing triclosan were tested for their antimicrobial effectiveness with a zone of
inhibition test. This involved placing ethylene oxide sterilized electrospun fabrics
containing different levels of triclosan on a confluent lawn of staphylococcus aureus (s.
aureus). Electrospun fabrics and 30µg tetracycline and 10µg gentamycin control discs
(BD) were incubated in 7.2pH, 100mM sterile phosphate buffered solution at 37°C. At
predetermined time points, samples were removed and placed on Mueller Hinton agar
plates streaked with s. aureus and incubated at 37°C for 16 hours. The width and height
of the region containing no s. aureus was measured and averaged to determine the zone
of inhibition.
To analyze thermal transition, differential scanning calorimetry (DSC) analysis
was employed using a Perkin-Elmer DSC-6. DSC data were analyzed to determine the
melting temperature (Tm), heat of fusion (∆Hf) and width of the melting endotherm at
half height (Whh). Inherent viscosity (IV) was determined using a Cannon-Fenske
viscometer with chloroform as a solvent at a concentration of 1mg/mL. Molecular
weight was measured by GPC with a DCM mobile phase, Styragel® columns, and a
Waters 2414 refractive index detector and data were analyzed to determine the number
average molecular weight (Mn), weight average molecular weight (Mw) and
polydispersity (PDI). Eluent from drug release studies were analyzed on a Waters HPLC
through a reverse phase C18 column with a mobile phase of acetonitrile and water, both
containing 0.1% TFA.
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PAX-6 containing different concentrations of triclosan were tested for possible
cytotoxic effects. Samples were sterilized by dipping in ethanol and allowed to dry in a
laminar flow hood for 1 hour and dried for an additional hour under vacuum.
L929 Fibroblasts (ATCC, Manassas, VA, passages 5 thru 8) were used for the
cytotoxicity study. Cell cultures were maintained at 37°C in a humidified, 5 % CO2/95%
air environment. Media was changed every 2 to 3 days. Complete media consisted of
Minimal Essential Medium, Eagle (ATCC, Manassas, VA) supplemented with 10% horse
serum (ATCC, Manassas, VA) and 1% penicillin/streptomycin (Invitrogen).
A 1.6% agarose solution was prepared and mixed (1:1) with complete media to
create a “soft agarose”. Components and solution were maintained at 45 ºC to prevent
agarose from solidifying. A dilute solution of neutral red dye (0.01 %) was prepared by
diluting the stock solution (1.4%, Sigma) with phosphate buffered saline (Sigma).
Fibroblasts were seeded at a density of 6.0 x 104 cells/cm2 (384,000 cells/mL) in
6-well plates and incubated at 37°C at 5 % CO2 for 48 hours. At that time, media was
aspirated and “soft agarose” was gently pipetted onto the cell layer. Plates were incubated
at 37 ºC for 30 minutes to allow the agar to solidify. At that time, 0.01% neutral red was
added on top of the agar and incubated further at 37 ºC for 30 minutes. Neutral red was
then aspirated from each well, being careful not to disturb the agar layer. Test materials
and control materials were added as the top layer to each well. Samples were prepared in
triplicate (one sample per well). Plates were then incubated for 24 hours and observed by
microscope. Digital images were taken to make qualitative observations. Tyvek® was
used as a negative control and pieces of copper wire (0.4mm diameter, 1cm long) were
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used as a positive control. Neutral red dye absorbs into active lysosomes. In an acidic
environment, such as the one maintained in lysosomes, neutral red maintains a
characteristic red color. In non-viable cells that cannot maintain acidity around
lysosomes, neutral red acts as a titrating indicator and changes to a transparent yellow; as
such, it is used as an indicator for cell viability.

Results and Discussion
Fabrics produced from PAX-6 containing individual drugs selected from those
noted in Table 5.1 were investigated for drug release into a predetermined volume of
100mM phosphate buffer at 37˚C, 7.2pH. Data from these tests were compiled and are
presented in Figure 5.1. The basic drug proxyphylline has the highest water solubility of
any drug used in the present study and also exhibits the greatest release, showing
approximately 90% release of the total loaded drug after only 2 hours, most of which
occurred in the first 10 minutes after placement in buffer. The acidic drug naproxen,
which is less soluble than proxyphylline, exhibits a release of 75% of the loaded drug
after 6 hours of release. This drug was the only one of those examined that did not
completely dissolve in the spinning solution. This characteristic was expected to retard
the release of naproxen from the fabric, which was not the case as almost the entire
amount of loaded drug was released from the fabric in a short amount of time. Fabric
loaded with the practically neutral acetaminophen released only about 15% of total
loaded drug and reached its maximum release in 4 hours – this rate is faster than the
release rate from the naproxen-loaded fabrics. The weakly acidic triclosan, the least
soluble of the investigated drugs in the present study, exhibited no measurable release for
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the first 24 hours. After an extended time-release study over 28 days, only 0.9% of the
loaded drug was observed. This amount of drug release was not a result of saturating the
solution, as triclosan can achieve up to ten times the maximum concentration observed in
this release study. These results suggest that (1) the drug solubility is the most important
determinant for modulating the release profile – maximum and minimum solubility are
associated with accelerated and retarded release profile, respectively, (2) higher
molecular weight of triclosan may have contributed to its slow release profile, (3) in
acidic and weakly acidic drugs (naproxen, acetaminophen, and triclosan) the effect of low
solubility on the release profile becomes more noticeable, and (4) the effect of molecular
weight on the modulation of release profile is not evident in this group of drugs.
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Figure 5.1. Release profile of drug-eluting PAX-6 electrospun fabrics in 7.2pH 100mM
phosphate buffer at 37°C. Average and standard deviation of four specimens reported.
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Stability through a sterilization cycle is an important criteria for any device to be
used in medical applications. To examine the stability of drug-loaded PAX-6 electrospun
fabrics, samples of each fabric were RCS sterilized at 5 and 10kGy and γ-sterilized at
25kGy to study the effect of irradiation on the thermal and drug release properties of each
fabric. Drugs were expected to remain practically unaltered and exhibit no significant
interaction with the polymer under the prevailing sterilization conditions. Hence, the
effect of irradiation on property retention of the PAX-6 polymer became the major focus
of this segment of the study. The effect of irradiation on the molecular dimensions of
PAX-6 electrospun fabric is described in Table 5.2. Irradiated and as-spun fabrics were
analyzed for thermal profile; this data is summarized in Table 5.3.

Table 5.2. Irradiation effect on the molecular dimensions of PAX-6 electrospun fabric
Irradiation
Level (kGy)
0
5
10
25

Molecular Weight
Mw
Mn
PDI
(kDa) (kDa)
127.8 354.7 2.78
137.2 388.8 2.83
114.3 315.8 2.76
82.0 260.1 3.17
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Viscosity
(dL/g)
1.61
1.42
1.27
0.99

Table 5.3. Thermal data of 3% drug-loaded PAX-6 electrospun fabric before and after
RCS sterilization at 5 and 10kGy and γ-sterilization at 25kGy irradiation dose, compared
to a model PAX-6 electrospun fabric containing no drug
Added Drug

n/a

Naproxen
Acetaminophen

Proxyphylline

Triclosan

Irradiation
level (kGy)
0
5
10
25
0
10
0
10
0
5
10
25
0
5
10
25

Tm (˚C)
151
152
155
157
151
156
150
154
150
152
154
155
151
153
154
156

DSC
∆Hf (J/g)
8
9
10
7
10
9
8
8
9
8
10
10
7
9
9
11

Whh (˚C)
15
14
13
13
15
14
15
14
14
16
15
15
16
15
15
14

As expected, most of the polymer chain degradation took place at or above the
10kGy dose,22,23 as shown in Table 5.2. Meanwhile, increasing the irradiation dose to
≥10kGy caused a decrease in the molecular weight and viscosity of the PAX-6 fabric,
which should affect drug release from this fabric. Results in Table 5.3 show that
irradiation and the subsequent decrease in molecular dimensions of the PAX-6 fabric
allowed increased and more uniform crystallization, up to a 10kGy dose. At 25kGy, the
degradation associated with increased radiation overcame the enhanced crystallizability
of the slightly-degraded polymer and yielded less-crystalline microfibers.
The addition of naproxen to the spinning solution resulted in microfibers
exhibiting an increase in the heat of fusion of the PAX-6 fabric. This increase indicates
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increased crystallite formation caused by nucleation in the presence of the drug.
Naproxen added to the electrospinning solution did not fully dissolve, but dispersed
homogenously through the solution. A 10kGy dose of radiation caused a decrease in the
heat of fusion and increase in the melt temperature, which could be attributed to slight
degradation and forced crystallization of the PAX-6 microfibers. The Whh data also show
a decrease after sterilization, which could be a result of the decreased heat of fusion. The
increase in melting temperature and decrease in the Whh of the drug-loaded fabric is
consistent with PAX-6 electrospun fabric containing no drug.
Acetaminophen was used as a drug additive to an electrospun fabric made of
PAX-6. The fabric was radiochemically sterilized at 10kGy in order to observe the
effects of sterilization on thermal properties and drug release profiles. Table 5.3
describes the changes in the thermal properties associated with the inclusion of drug in
the electrospinning solution and γ-irradiation, which exhibit similar effects to those noted
in the naproxen-loaded fabric. Inclusion of acetaminophen decreased the Whh, which
indicates that the drug interferes with the formation of large crystallites of PAX-6 in the
electrospun microfibers. In both the drug-loaded and unloaded PAX-6 fabrics, 10kGy
dose of radiation increased the Tm by 4˚C. The increase in the heat of fusion in
conjunction with a decrease in the Whh is evidence of slight degradation and increased
crystallization showing more uniform crystallite size distribution as a result of irradiation.
Samples of PAX-6 electrospun fabric loaded with proxyphylline were assessed
for polymer stability through RCS sterilization protocols at 5 and 10kGy and γsterilization at 25kGy. the melting temperature increased with increasing levels of

115

irradiation for both drug-loaded fabrics and those containing no drug. Other differences
were observed in the drug-loaded fabric but no inferences could be made between
irradiation level and its effect on the thermal properties. Crystallite formation around the
diffused drug could be more stable than in the PAX-6 fabric with no added drug, which
could explain the decreased effect of irradiation dose on the thermal properties of the
proxyphylline-loaded PAX-6 fabrics
Triclosan-loaded PAX-6 fabrics were made and, as previously observed,
increased irradiation level increased the melting temperature and increased the heat of
fusion while lowering the Whh. The addition of triclosan to the spinning solution did not
greatly inhibit crystallization but did create nucleation sites that allowed further
crystallization with increased radiation dose.
Naproxen-loaded fabrics before and after sterilization were analyzed for batch
drug release properties in a 7.2pH phosphate buffered solution at 37˚C to mimic
physiological conditions. Figure 5.2 describes the release profile of the non-sterilized
drug-containing electrospun fabric over a 24-hour period. The drug-eluting fabric
showed a basic burst release profile with a maximum release of 76% of total loading after
6 hours, which indicates a diffusion-controlled release system. After 4 hours of
increasing release, a drop in the measured release of the drug occurred. PAX-6 is a
slightly crystalline material that can be annealed to increase crystallinity. After several
hours in buffered solution, crystallinity in the PAX-6 increased; the PAX-6 possibly
adsorbed some of the naproxen which caused the reduction in analyzed drug
concentration. This phenomenon is not necessarily clinically relevant as the drug would
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be transported from the implant site before adsorption could occur. Figure 5.2 also
describes release data for drug-eluting electrospun fabric after a 10kGy radiochemical
sterilization protocol. These data points show less total drug release, with only about
60% of the total available drug being released after 24 hours. After seven days, this
release increased to about 70% release while there was no further release of naproxen
from the non-irradiated sample. During spinning, the low molecular weight drug tends to
migrate to the surface of the microfiber. The drug molecules close to the surface exhibit
diffusion-controlled release properties, while drug embedded deeper in the fabric may
release over a longer period of time through diffusion and degradation-assisted diffusion
as microfiber degradation assists in the release of naproxen from the fabric. Radiation
causes the PAX-6 electrospun fabric to slightly degrade. The degradation products are
acidic and could form stronger hydrogen bonds with acidic naproxen, but would not be
expected to form in the other drugs.
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Figure 5.2. Batch release profile of Naproxen from electrospun PAX-6 fabric containing
3% drug. Average and standard deviation of four specimens reported.

Batch release of the acetaminophen-loaded fabrics in 7.2pH 100mM phosphate
buffered solution at 37˚C exhibited a typical burst-release profile with a maximum
release of 13.4% of total loaded drug after 24 hours for the non-sterilized sample, as
described in Figure 5.3. The release occurred within the first 6.6 hours after immersion
into the buffered solution. Once sterilized, however, acetaminophen released more
completely; the 10kGy-irradiated fabric released 19% of total loaded drug after 4 hours.
This amount is 40% more than the non-irradiated fabric and the release occurred more
than 2 hours faster. After a 10kGy dose of radiation, the PAX-6 fabric was slightly
degraded, which allowed faster drug release. The irradiated sample has a greater ability
to crystallize after annealing, which may result in readsorption of the drug after
annealing.
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Figure 5.3. Batch release of acetaminophen from PAX-6 electrospun fabric containing
3% drug, before and after a 10kGy RCS sterilization protocol. Average and standard
deviation of four specimens reported.

Release studies were performed on proxyphylline-loaded PAX-6 electrospun
fabrics placed in 7.2pH 100mM phosphate buffered solution at 37˚C. Proxyphylline is
the most water soluble of the drugs studied and the release of non-sterile proxyphylline
from electrospun microfibers occurred quickly, with the maximum amount of drug
detected in the second hour of release (Figure 5.4). After any amount of irradiation,
however, drug release was significantly reduced, which could be associated with partial
degradation of the drug – the basic functionalities can be susceptible to radiation and/or
radiation-induced degradation. In this case, there are two factors combining to affect
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drug release: polymer degradation and drug degradation. Five and 10kGy doses of
irradiation result in relatively slower drug release rates while the increased degradation
associated with a 25kGy level of irradiation yields the fastest drug release rate of any
treatment. For lower levels of irradiation dose, the degradation of drug has a greater
effect on the release than degradation of the polymer. This is reasonable to expect for the
amine-bearing drug and its susceptibility to degradation at low radiation dose. The
polymer crystallinity is increasing, causing a slower release in drug. At 1 hour, the
sample sterilized at 5kGy exhibited the lowest release while the sample irradiated at
10kGy showed a higher release. Between 5- and 10kGy, increasing the γ-dose caused
increased polymer degradation which lead to faster release of drug. The highest
irradiation dose caused the greatest degradation in the molecular dimensions of PAX-6
and surpassed proxyphylline degradation as the dominating factor controlling release.
The highest irradiation dose resulted in the fastest release, with most of the released
proxyphylline detected in solution in the first 20 minutes. From this data, sterilization at
25kGy is not a viable option of sterilizing proxyphylline-loaded PAX-6 electrospun
fabrics, unless a very fast release is desirable. Sterilization with lower levels of γirradiation produces a slower and more controlled release profile.
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Figure 5.4. Batch release of proxyphylline from PAX-6 electrospun fabric containing 3%
drug, before and after RCS and γ-sterilization protocols. Average and standard deviation
of four specimens reported.

Triclosan drug release rate was determined by placing drug-loaded electrospun
fabrics in 7.2pH 100mM phosphate buffered solution at 37˚C and testing samples at
various time points to obtain a release profile, as shown in Figure 5.5. In the non-sterile
fabric, only 0.09% of the loaded drug was determined in buffer through 28 days; this
release level was achieved in the first 5 days and did not change. After sterilization, the
amount of triclosan release was reduced to about 0.04% of the total drug in the fabric
sample, less than half the release observed in the non-irradiated sample. Amine groups
are susceptible to degradation and the γ-dose used in this study may have resulted in the
cleavage of chlorine from the drug, which would modify the absorptive properties of the
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drug, which would in turn result in a portion of the released drug to not be detected by
HPLC. The amine susceptibility may be one reason for the decreased release of the γirradiated Triclosan. In addition, the low solubility of triclosan did not lead to an early
burst as in the other drugs included in this study. In this case, drug release occurs as the
microfiber matrix erodes.
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Figure 5.5. Batch release profile of triclosan from PAX-6 electrospun fabric containing
3% drug, before and after RCS and γ-sterilization protocols. Average and standard
deviation of four specimens reported.
To determine the effectiveness of triclosan release, a zone of inhibition study was
performed on PAX 6 fabric containing 0, 0.2, and 2.5 wt% triclosan. Zones were
compared to tetracycline and gentamycin controls at 0, 1, 2, and 7 days. Results for this
test were recorded in Table 5.4. Results indicate no initial inhibition caused by the
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electrospun fabric, but after incubation for one day the material displayed a 12.8mm zone
of inhibition. This result could be due to low Mw compounds leaching from the
electrospun fabric or degradation products leaching due to hydrolysis. The addition of
0.2 wt% triclosan to the electrospun fabric resulted in a similar zone of inhibition profile
to the fabric containing no drug. At Day 0, there was no inhibition of s. aureus by PAX6 fabric containing 0.2% triclosan, followed by 11.0 to 11.7mm zone of inhibition after
incubation. These results indicate no enhanced inhibition in PAX 6 fabric with lower
drug concentration.

Table 5.4. Zones of inhibition of PAX 6 electrospun fabrics and tetracycline and
gentamycin controls after incubation in 7.2pH, 100mM phosphate buffered solution at
37°C.
Material
PAX 6
PAX 6 + 0.2% Triclosan
PAX 6 + 2.5% Triclosan
Tetracycline disc, 30µg
Gentamycin disc, 10µg
*
Average of three specimens

Zones of Inhibition, mm*
Day 0
Day 1
Day 2
Day 7
0
12.8
12.7
12.3
0
11.7
11.0
11.3
21.8
20.5
21.8
22.8
30.5
34.0
34.0
34.0
26.0
30.5
30.5
30.5

Electrospun PAX-6 fabric containing 2.5% triclosan exhibited a 21.8mm zone of
inhibition at Day 0, indicating an effective release of triclosan during the 16 hour
incubation on the s. aureus-seeded agar plates. After incubation in buffer, the fabric still
released effective levels of drug during incubation on the seeded agar plates, resulting in
approximately the same zone of inhibition. The measured zone did not seem affected by
the release of PAX-6 degradation components, which was the only source of inhibition
for PAX-6 fabrics containing no drug or 0.2% drug. Inhibition of s. aureus in this case is
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caused solely by the release of an effective dose of triclosan and was not enhanced by the
PAX-6 fabric. This inhibition was lower than tetracycline and gentamycin control discs,
but may be enough to protect a wound site treated with electrospun wound dressings
through 7 days, a critical stage in wound healing. If a higher level of inhibition is
necessary, the dose of drug can be optimized by varying the concentration in PAX-6
fabric and performing drug release tests, along with zone of inhibition testing to describe
any enhanced therapeutic effects.
As shown in Figure 1.4a and 1.4b, cells exposed to Tyvek® stained red, indicating
cell viability. Cells exposed to copper wire did not stain, indicating the non-viability of
the cells. Fibroblasts exposed to PAX-6 exhibited similar reaction to those exposed to
sterile Tyvek®, indicating the material had no negative effect on cell viability. Similarly,
electrospun fabrics made from PAX-6 with 0.2% and 2.5% triclosan were not cytotoxic
to mouse fibroblasts.

(a)

(b)

Figure 5.6. Cell viability of L929 mouse fibroblasts after exposure to (a) Negative control
(Tyvek®) and (b) Vehicle control (copper wire) after staining. Red-stained cells were
viable at the time of staining.
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(a)

(b)

(c)
Figure 5.7. Cell viability of L929 mouse fibroblasts after exposure to (a) PAX-6
elecotrospun fabric, (b) PAX-6 electrospun fabric containing 0.2% triclosan and (c)
PAX-6 electrospun fabric containing 2.5% triclosan.
Conclusion
Electrospun fabrics were prepared by combining a continuous polymeric matrix
of PAX-6 and either naproxen, acetaminophen, proxyphylline or triclosan. Drug
solubility and structure are the major factors affecting release rate from the electrospun
fabrics. Increasing solubility is the primary determinant of increasing the total
percentage of drug released, but does not necessarily have an effect on the rate of drug
release. Sterilization of the fabrics also has an effect on the drug release, as irradiation
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can degrade the polymeric matrix. In some cases, polymer degradation increases the rate
at which the drug can diffuse from the surface, as was the case with a 10kGy dose on
acetaminophen-loaded fabrics and a 25kGy dose on proxyphylline-containing electrospun
fabrics. Irradiation can also slow down the release of drug. Five and 10kGy doses of
irradiation on proxyphylline-containing fabrics doubled the time it took to release the
drug. In the case of an acidic drug, naproxen, acidic degradation products of the polymer
can hydrogen bond with some of the drug, decreasing the amount of drug available for
immediate release. The dispersed naproxen had the greatest release stability through the
sterilization cycle, which was expected as it was not fully dissolved into the microfiber
matrix. Electrospun PAX 6 fabrics containing 2.5% triclosan were shown to deliver an
effective level of drug, causing inhibition of staphylococcus aureus through 7 days, a
critical time in wound healing. Additionally, triclosan-loaded electrospun PAX-6 fabrics
were shown to be compatible with cells.
This study shows the considerations that must take place when designing active
electrospun systems with the purpose of releasing drug. Notably, it is the release rate of
the final sterilized device that is most important. Results of this study indicate that drug
can be successfully incorporated into electrospun scaffolding, which can in turn be
sterilized and be used in clinically-relevant devices. These devices could include
antimicrobial dressings for infected wounds. Also, because the fibrous matrix can be
produced from biocompatible, absorbable components, they can be used for transient
placement applications. At the very least, any residual fibers left in the wound should not
elicit a significant tissue response or be responsible for inhibiting wound healing.
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CHAPTER 6
ELECTROSPUN MODEL POLYETHER-ESTERS AND THE EFFECTS OF MAINCHAIN PEG CONTENT ON KEY MICROFIBER PROPERTIES

Introduction
Biomedical devices have become increasingly complex in recent years and, as
such, the call for novel materials with specific characteristics has increased. One area of
particular interest is the field of electrostatic spinning. This unique method for the
creation of micro- and nanoscale fibers has gained increasing attention as a technology to
produce highly porous, non-woven fabrics with precisely tailored properties. Possible
medical uses of these fabrics include tissue engineering scaffolds and drug-eluting or
haemostatic surgical gauze. For many of these applications, it is beneficial for the
electrospun constructs to be made of bioabsorbable materials. Traditional absorbable
polymers are not ideal for some applications due to their intrinsic hydrophobicity. Many
developments in surface technology have occurred to make these materials more
hydrophilic1,3. Among these processes is a sodium hydroxide treatment. However, this
treatment can damage the material properties, especially of fibers made from delicate
materials having a very fine architecture. For some applications, a fabric with variable
hydrophilicity may be advantageous.2 A class of absorbable polymers containing
hydrophilic components and having mechanical properties sufficient for the production of
electrospun non-woven fabrics would be highly desirable.
One possible application for single-component electrospun fabrics prepared from
an amphiphilic polymer is wound dressings. The ability of the hydrophilic component to
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absorb moisture will allow application in exudative wounds, and will maintain a moist
wound environment and accelerate healing. Additionally, these materials may facilitate
autolytic debridement. The ability to provide autolytic debridement is in direct contrast
to gauze, which is the most widely-used wound dressing.10-12 The application of gauze
can lead to a dry wound bed, which can lead to painful dressing changes or can rewound
the placement site. Newer technologies have been developed to provide alternatives to
traditional gauze treatment, including alginates, hydrocolloids, transparent films, and
others. Wound dressings should be consistently designed to decrease healing time,
minimize scar formation, prevent infection, and heal the wound site to pre-injury
functionality. By coupling electrospinning technology with tailored absorbable
polymers, a device can be designed to provide improved wound healing.
An ideal scaffold for tissue engineering would combine high porosity with
interconnected pores, variable but controllable hydrophilicity, structural stability and
biodegradability.4 A common method for producing porous, non-hydrogel matrices is
through particulate leaching or gas foaming techniques.5,6 Creating a fully open-pore
system is difficult and many techniques leave process-related impurities which can be
detrimental to differentiating and proliferating cells. Materials produced with an
intrinsically open pore system would avoid any complications associated with leaching
and foaming techniques.
Polyethylene glycol (PEG) is a hydrophilic and water soluble material often used
to prepare hydrogels.7 However PEG-based systems traditionally do not have the
processability of other types of polymer systems and, as such, have not been widely used
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as a basis for fiber-forming materials. PEG-based systems can be at the least
amphiphilic, if not completely hydrophilic, which makes them attractive for many
medical applications. Designing a polymer system comprising a PEG chain in
combination with traditionally high strength fiber-forming chains (e.g. polylactide)
provides a material with the ability to be processed into fibers via the electrospinning
process.
It may be shown that requirements of different biomedical applications are better
suited by fabrics with slight variations in properties such as hydrophilicity, tensile
strength and absorption rate. It was reported earlier that electrospun fabrics can be
prepared with two materials having very different properties (Chapter 3). In that case,
materials were shown to separate during electrospinning, forming fibers having surfaces
with different properties than the respective cores. Alternatively, it would be
advantageous to process a single polymer that combines the advantages of hydrophobic
and hydrophilic absorbable polymers.
Application of electrospinning techniques to polymers with clinically desirable
biomedical properties provided an incentive to develop new materials for existing and
new applications. This, coupled with Poly-Med, Inc.’s continued interest in developing
novel absorbable polymer systems for medical applications prompted the present study.
In the initial phase of the study, four polymers were designed to have varying degrees of
hydrophilicity with similar molecular weights. Electrospun fabrics and solvent-cast films
were produced from each polymer and analyzed to determine (1) the effect of PEG
content on the final fabric properties, and (2) the difference between the bulk material
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and the electrospun fabric. Analyses included the determination of the initial properties
of electrospun fabrics and films (thermal properties, bursting strength properties, and
surface energy) and the degradation rate of the selected materials.

Materials and Methods
Three amphiphilic polymers (AMP-23, 24 and 25) were prepared as tri-block
copolymers by the ring-opening polymerization of a mixture of 95/5 (molar) llactide/trimethylenecarbonate initiated by the terminal hydroxyl groups of hydrophilic
poly(ethylene glycol) (PEG).8 Final theoretical PEG concentrations of 6.7, 9.3 and 13.3
wt% were chosen based on the average molecular weight of PEG used: 10, 14 and 20kDa
respectively, resulting in copolymers with theoretical molecular weights of 150kDa. An
additional polymer (AMP-26) was prepared in the same manner with 10kDa PEG as the
initiator, with 9.3 wt% PEG in the main chain. The theoretical molecular weight of this
polymer was 107kDa. The polymers were purified before use by precipitation of their
solutions in a non-solvent liquid.
AMP-23, AMP-24, AMP-25, and AMP-26 were electrospun from a solution
containing 20 w/v% polymer with 1:1 DCM:CHCl3 solvent, with a voltage differential of
15kV and a tip-to-collector distance (TCD) of approximately 7”. Electrospun fabrics
were produced using the same processing conditions to isolate the effect of polymer
chain variations on final fabric properties.
Films were produced for comparison with electrospun fabrics, in order to
determine the effect of construct geometry on the final properties of each polymer. Films
were produced from solutions made from 20 w/v% polymer with 1:1 DCM:CHCl3
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solvent. Polymer solutions were solvent cast to produce thin films (ca. 0.5mm thickness)
in air until no longer tacky and then fully dried under reduced pressure to remove any
residual solvent.
To analyze films and electrospun fabrics with respect to thermal transitions,
differential scanning calorimetry (DSC) analysis was employed using a Perkin-Elmer
DSC-6. Thermal analysis was performed by heating samples weighing approximately
5mg at 20°C/min under nitrogen purge. Inherent viscosity (IV) was measured using a
Cannon-Fenske viscometer with CHCl3 solvent. IV samples (25mL total volume) were
analyzed at 1mg/mL concentration at 30°C. Molecular weight was determined using gel
permeation chromatography (GPC) with a DCM mobile phase, Styragel® columns, and a
Waters 2414 refractive index detector. Fabric morphology was assessed by sputter
coating samples with gold and using scanning electron microscopy (SEM) with a Hitachi
S3500-N SEM system. Fiber dimensions were obtained by measuring the width of
random samples of fibers as seen by SEM and comparing to a scale on the SEM plot;
results were reported as average with one standard deviation. At least 20 measurements
were obtained from each SEM image and fiber diameters were compared using an
unpaired Student’s t-test. Surface energy was determined by static contact angle analysis
using a Thwing-Albert PG-X goniometer. Static contact angle was measured with the
PG-X dropping 4µL of distilled water on the surface of the sample film. Digital images
were recorded and contact angle determined using the PG-X software.
To examine the differences in absorption profile of the films and corresponding
fabrics, accelerated in vitro mass loss was performed using a newly developed protocol9
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that calls for the placement of approximately 100mg specimens in 12pH 200mM
phosphate buffer at 37°C. Films or fabrics made from AMP-23, AMP-24, and AMP-26
were removed at 2.8, 8, 18.5, and 23 hours, dried under reduced pressure, and weighed to
determine the percent weight loss. Similarly, AMP-25 was removed after 0.8, 1.5, and
2.8 hours of incubation, dried under reduced pressure, and weighed. Further analysis was
performed on the degraded samples to determine the effect of morphology on the
degradation of these materials.
AMP fabrics were tested for possible cytotoxic effects. Samples were sterilized by
dipping in ethanol and allowed to dry in a laminar flow hood for 1 hour and dried for an
additional hour under vacuum.
L929 Fibroblasts (ATCC, Manassas, VA, passages 5 thru 8) were used for the
cytotoxicity study. Cell cultures were maintained at 37°C in a humidified, 5 % CO2/95%
air environment. Media was changed every 2 to 3 days. Complete media consisted of
Minimal Essential Medium, Eagle (ATCC, Manassas, VA) supplemented with 10% horse
serum (ATCC, Manassas, VA) and 1% penicillin/streptomycin (Invitrogen).
A 1.6% agarose solution was prepared and mixed (1:1) with complete media to
create a “soft agarose”. Components and solution were maintained at 45 ºC to prevent
agarose from solidifying. A dilute solution of neutral red dye (0.01 %) was prepared by
diluting the stock solution (1.4%, Sigma) with phosphate buffered saline (Sigma).
Fibroblasts were seeded at a density of 6.0 x 104 cells/cm2 (384,000 cells/mL) in
6-well plates and incubated at 37°C at 5 % CO2 for 48 hours. At that time, media was
aspirated and “soft agarose” was gently pipetted onto the cell layer. Plates were incubated
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at 37 ºC for 30 minutes to allow the agar to solidify. At that time, 0.01% neutral red was
added on top of the agar and incubated further at 37 ºC for 30 minutes. Neutral red was
then aspirated from each well, being careful not to disturb the agar layer. Test materials
and control materials were added as the top layer to each well. Samples were prepared in
triplicate (one sample per well). Plates were then incubated for 24 hours and observed by
microscope. Digital images were taken to make qualitative observations. The absence of
sample was used as a negative control and pieces of copper wire (0.4mm diameter, 1cm
long) were used as a positive control. Neutral red stain is transported across active cell
membranes by endocytosis and is absorbed into lysosomes. In an acidic environment,
such as the one maintained in lysosomes, neutral red maintains a characteristic red color.
In non-viable cells that cannot maintain acidity around lysosomes, neutral red acts as a
titrating indicator and changes to a transparent yellow; as such, it is used as an indicator
for cell viability.

Results and Discussion
6.1 Electrospinning and Film Casting of AMP Polymers

SEM analysis showed that each solution formed a typical non-woven fibrous mat
when electrospun. Table 6.1 presents the average diameter of each electrospun mat.
Random sampling showed AMP-24 electrospun fabric to have the smallest average
diameter, along with the most uniform diameter distribution. AMP-25 was measured as
having the largest average diameter with the largest standard deviation. Differences in
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diameter of AMP-23 and AMP-26 electrospun fibers were not statistically significant
(p=0.30).

Table 6.1. Average diameters of electrospun AMP fibers created from 20 w/v% solutions
with 1:1 DCM:CHCl3 solvent, ∆V=15kV, TCD=7”
Polymer
AMP-23
AMP-24
AMP-25
AMP-26

Average
Diameter, µm
6.6
3.4
8.6
6.1

Standard
Deviation, µm
1.3
0.8
2.4
1.7

Electrospun fabrics and films produced from the four types of AMP polymers
were analyzed for molecular weight and thermal characteristics. In general, electrospun
fabrics exhibited lower polydispersity indices (PDI) than films cast from the same
polymer, as can be seen in Table 6.2. During the electrospinning process, some material
collected and dripped from the needle tip. This material could have contained low
molecular weight components, causing the polymer to be purified as it was electrospun.
The Mn was also typically higher in electrospun fabrics.
Table 6.2. Molecular weights of AMP electrospun fabrics and solvent-cast films
Material
AMP-23
AMP-24
AMP-25
AMP-26

Form
Fabric
Film
Fabric
Film
Fabric
Film
Fabric
Film

Mn ,
kDa
61
18
25
19
27
27
36
14
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Mw, kDa

Mp, kDa

PDI

142
136
63
75
95
99
118
113

151
143
33
35
128
126
34
35

2.32
7.80
2.53
4.05
3.51
3.73
3.26
8.30

Contact angle is a means of measuring the free surface energy of a surface, and is
used to classify materials as hydrophilic or hydrophobic. The AMP family of polymers
has been designed as amphiphilic, meaning the polymer chain contains constituents that
have both hydrophilic and hydrophobic tendencies. Contact angle analysis can be
complicated by surface topography, especially in materials with small pore sizes such as
electrospun fabrics. The complex topography can mask differences in surface free
energy measured by contact angle; however, films produced from the AMP polymers can
be used to determine the bulk contact angle of each material.
Table 6.3 describes the contact angle of films cast from AMP-23, AMP-24, AMP25, and AMP-26. A film cast from AMP-23 displayed the second highest contact angle
and showed the least change over the 10-minute test. AMP-24 film was tested with a
slightly higher contact angle, but showed a greater change over the duration of the test.
The greatest change in contact angle was seen in the film cast from AMP-25. This
material also displayed the lowest initial contact angle, meaning it was the most
hydrophilic of the four polymers. Increasing the PEG content of these three materials to
about 13% greatly increased the hydrophilicity of the bulk material. AMP-26, which was
designed to have a lower molecular weight but the same PEG ratio as AMP-24, exhibited
a lower contact angle than the AMP-24 film. The lower value indicates a molecular
weight dependence on the hydrophilic nature of the AMP family of polymers. In the
engineering of wound dressings, the ability to optimize the material hydrophilicity could
lead to a better product. More-hydrophilic materials could also be better suited for
exudative wounds or may better maintain a moist wound healing environment.
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Table 6.3. Contact angle measurements of solvent-cast films made from AMP polymers
with water as test fluid. Results are an average of 10 images taken over 5 seconds at each
time point.
Sample
AMP-23 film
AMP-24 film
AMP-25 film
AMP-26 film

Initial
84
91
56
79

Static Contact Angle, °
5 minutes
10 minutes
81
78
86
82
49
45
72
69

Thermal analysis data of AMP electrospun fabrics and cast films is summarized in
Table 6.4. In each case, the crystallization temperature (Tc) and heat of crystallization
(∆Hc) of the films was higher than that of the electrospun fabrics, indicating the
electrospun fabrics crystallized more readily. Films also exhibited two peaks in the melt
endotherm, indicating high non-uniformity or a bimodal distribution of crystallite sizes.
The small diameter of electrospun fibers, coupled with the orientation effects associated
with the electrospinning process, limited the crystallite distribution to the primary, higher
temperature peak. The bimodal distribution could also be attributed to the slower
crystallization of cast films compared to electrospun fabrics. Heat of fusion (∆Hf) was
similar for electrospun fabrics and cast films from the same materials. The relatively low
heat of fusion indicates a more amorphous, softer surface, which could be more
compatible with cells and result in improved cellular attachment.
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Table 6.4. Thermal transitions of AMP electrospun fabrics and solvent-cast films
Material

Tg, °C
DMA DSC

Tc,
°C

∆Hc,
J/g

AMP-23
70.5 55.2 94.7 22.5
fabric
AM-23
58.5 51.9 106.7 28.7
film
AMP-24
59.8
45
85.5 23.8
fabric
AMP-24
59.7 52.2 104.0
35
film
AMP-25
62.1 49.9 90.0 21.0
fabric
AMP-25
63.6
54 105.1 32.0
film
AMP-26
61.4 50.8 88.3 26.5
fabric
AMP-26
61.3 52.4 105.3 29.1
film
*
Shoulder temperature in melt endotherm

Tm, °C

∆Hf, J/g

Whh, °C

159.3

25.7

7.4

152*, 159.7

25.1

7.8

159.0

28.9

6.3

151*, 160.4

30.2

4.7

160.1

29.1

7.1

152*, 161.3

26.3

4.6

160.6

23.4

7.9

151*, 160.8

24.8

5.1

Fiber diameter was not related to thermal events, but the fiber with the largest
standard deviation in diameter corresponded to the highest PDI (AMP-25). AMP-23
fabric was tested as having a significantly higher Mn, as well as a higher glass transition
temperature. Other initial properties were similar for the fabrics and films.

6.2 Cytotoxicity of Electrospun AMP fabrics on L929 Mouse Fibroblasts

An important element to any medical device is the material safety when in contact
with host tissue. Cytotoxicity is one indicator of material safety, and is commonly used
as an initial material screen. Copper wire has a cytotoxic effect on mouse fibroblasts, as
seen by differences in uptake of red stain in Figure 6.1. Cells exposed to all AMP fabrics

141

maintained viability under the test conditions, as seen in Figure 6.2. Cellular viability
indicates that all AMP fabrics are contenders for continued evaluation as medical fabrics.

(a)

(b)

Figure 6.1. Cell viability of L929 mouse fibroblasts after exposure to (a) negative control
(cells only) and (b) vehicle control (copper wire) after staining. Red cells were viable at
the time of staining.
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(a)

(b)

(c)

(d)

Figure 6.2. Cell viability of L929 mouse fibroblasts after exposure to (a) AMP-23, (b)
AMP-24, (c) AMP-25, and (d) AMP-26.

6.3 In Vitro Absorption of AMP Electrospun Fabrics and Cast Films

To determine differences in absorption profile of the various AMP electrospun
fabrics and cast films, materials were incubated in a buffered solution under accelerated
conditions so that changes associated with degradation could be ascertained. A key
performance indicator of absorbable materials is the mass loss profile. Figures 6.3, 6.4,
6.5, and 6.6 describe the mass loss profile of AMP fabrics and films. In each case,
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electrospun fabric exhibited faster mass loss. This enhanced rate is due to a significant
increase of surface area associated with electrospun fabrics. The exception to this
observation was associated with materials produced from AMP-25. Differences in
degradation rate between electrospun fabric and film could be masked by the fast
degradation rate of these materials. AMP-25 contained the highest level of PEG, which
caused the fastest mass loss. Additionally, the mass loss profile showed a relatively
slower degradation profile until approximately 10% mass loss, after which point the
materials lost mass relatively quickly.
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Figure 6.3. Mass loss profile of AMP-23 electrospun fabric and cast film in 12pH
200mM phosphate buffered solution at 37°C
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Figure 6.4. Mass loss profile of AMP-24 electrospun fabric and cast film in 12pH
200mM phosphate buffered solution at 37°C
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Figure 6.5. Mass loss profile of AMP-25 electrospun fabric and cast film in 12pH
200mM phosphate buffered solution at 37°C
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Figure 6.6. Mass loss profile of AMP-26 electrospun fabric and cast film in 12pH
200mM phosphate buffered solution at 37°C

Mass loss profiles of the four electrospun fabrics, as found in Figure 6.7,
exhibited dependence on (1) the percentage of PEG in the main chain of the polymer, and
(2) the initial designed molecular weight of the polymers. AMP-23 was prepared using a
calculated PEG concentration of 6.7%. AMP-24 and AMP-25 were designed to contain
9.3 and 13.3% PEG, respectively. An almost linear decrease occurred in the time
required to reach 50% mass loss, with increase in PEG concentration. Additionally, by
lowering the designed molecular weight by 29% while retaining the PEG concentration
(AMP-24 and AMP-26), a drastic increase in mass loss rate was observed. The ability to
control mass loss profile with changes in polymer molecular weight displays the
flexibility in design of mass loss profiles from polymers produced of the same constituent
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materials. Flexibility is of importance to wound healing because a tailored design can
result in optimized combination of degradation rate and hydrophilicity.
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Figure 6.7. Mass loss profiles of AMP electrospun fabrics in 12pH 200mM phosphate
buffered solution at 37°C

As fabrics and films undergo hydrolytic degradation, other properties will be
affected as well. Thermal changes are one example of properties that can be altered
during degradation, as described in Table 6.5. Initially, the thermal profile of all fabrics
and films included a relatively large crystallization endotherm and melting endotherm. In
most cases, the heat of crystallization (∆Hc) was larger than the heat of fusion (∆Hf). The
difference in ∆Hc and ∆Hf indicates the materials are initially amorphous, but can be
crystallized by heating. The heat of crystallinity generally decreased while the heat of
fusion remained the same, indicating solution- and/or thermally-induced crystallization
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due to incubation at 37°C. In the case of fabric and film produced from AMP-26, the
material crystallized during incubation, indicated by the disappearance of the
crystallization endotherm. The heat of fusion is mass-dependant and did not significantly
change for any specimen, which indicates the concentration of crystallizable material did
not change as the fabrics degraded. The data suggests that degradation occurred in both
the amorphous and crystalline regions at approximately the same rate, which could mean
the material is degrading from the surface. Similar losses in the amorphous and
crystalline regions could be from the accelerated rate of degradation caused by the test
conditions. Additionally, the crystallization temperatures (Tc) generally decrease with
fabric and film degradation, which can be associated with mass loss.
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Table 6.5. Thermal transitions of AMP electrospun fabrics and cast films after incubation
in 12pH 200mM phosphate buffered solution at 37°C
Material
AMP-23
fabric

AM-23
film
AMP-24
fabric
AMP-24
film

AMP-25
fabric

AMP-25
film

AMP-26
fabric

AMP-26
film

Incubation
Time, hrs
0
2.75
8.03
23.12
0
2.75
8.03
23.12
0
2.75
0
2.75
8.03
23.12
0
0.82
1.45
2.75
0
0.82
1.45
2.75
0
2.75
8.03
23.12
0
2.77
8.03
23.12

Tc, °C

∆Hc, J/g

Tm, °C

∆Hf, J/g

Whh, °C

94.7
91.1
90.6
86.2
106.7
86.6
84.1
88.6
85.5
89.5
104
97.4
95.7
90.9
90
84.3
84.2
88.1
105.1
98
94.4
94.3
88.3
77.1
76.9
105.3
-

22.5
18.3
22.5
18.9
28.7
23.5
16
15.7
23.8
4.1
35
15.8
19.1
16.6
21
6.1
6.7
2.8
32
20.5
16.7
15.4
26.5
8.8
10
29.1
-

159.3
158.2
158.1
157.7
159.7
158.3
157.9
158.5
159
158.3
160.4
160.9
159.9
159.3
160.1
159.1
159.8
159.1
161.3
160
160.3
161.3
160.6
158.9
157.8
158.1
160.8
160.2
160
159.4

25.7
25.4
26.7
22.8
25.1
26.8
23.8
22.6
28.9
30.7
30.2
30.6
32.8
34.5
29.1
28.1
29.2
29.3
26.3
27.9
26.4
27.1
23.4
28.9
29.6
27
24.8
30.8
29.3
29.5

7.4
6.2
6.6
7.3
7.8
5.9
6.5
5.9
6.3
7.4
4.7
5.9
5
5.6
7.1
6.7
7.3
7.1
4.6
5.2
5.4
5.4
7.9
7.4
8.8
9.1
5.1
5.8
5.5
5.8

SEM images of AMP-24 electrospun fabric further show the effect of
degradation. Figure 6.8 is an image of electrospun AMP-24 before incubation in buffer
and displays the structure of the fabric. After 8 hours of incubation in 12pH 200mM
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phosphate buffered solution, the fabric lost approximately 18% of its initial mass.
Visually, fibers retained basic shape properties, but the fabric appeared more compressed,
as seen in Figure 6.9. After incubation for 23 hours, which correlates to about 85% mass
loss, fibers can still be visualized by SEM. Fibers at this stage of degradation appear
“ghost-like” and are significantly smaller in diameter than less-degraded samples, but the
fiber diameter is not reduced enough to account for the measured 85% mass loss. Fibers
that retain shape as they degrade still provide a location for cellular attachment and can
retain the same scaffold shape during wound healing. Ideally, fibers and fabric will retain
shape through the critical wound healing period, typically about two weeks.

Figure 6.8. SEM micrograph of AMP-24 electrospun fabric.

150

Figure 6.9. SEM micrograph of AMP-24 electrospun fabric after 8 hours in 12pH
200mM phosphate buffered solution at 37°C

Figure 6.10. SEM micrograph of AMP-24 electrospun fabric after 23 hours in 12pH
200mM phosphate buffered solution at 37°C.

151

For wound healing applications, shape retention is an important property. As the
material undergoes hydrolytic degradation, the electrospun fibers do not lose shape until
nearly complete mass loss. The fibers do not disintegrate, leaving a mass of short pieces,
nor do the fibers dissolve into a viscous liquid. These fabrics, when applied as a
dressing, will retain porosity, allowing oxygen diffusion to the wound surface, and should
maintain a moist environment throughout the wound healing process.

Conclusions
Electrospun fabrics have tailorable properties and may be formed from
traditionally non-fiber forming and difficult-to-melt process (i.e. melt blowing) materials.
The AMP family of polymers is one such example, and fabrics produced therefrom have
been shown to have biomedically-relevant properties. Unlike previously-reported
materials (Chapter 2), the electrospinning process did not cause significant changes in the
crystallinity of small-diameter fabrics. Electrospun fabrics, however, did degrade at a
faster rate than their cast film counterparts, which can be attributed to the great increase
in surface area. Material selection was shown to be important due to variation in
degradation rates of different materials. By increasing the PEG component, electrospun
fabrics degraded much more rapidly. This tailorability in degradation rate is important in
optimizing a wound dressing fabric. Another positive attribute of these electrospun
fabrics is that they maintain their basic shape, even after high mass loss, which is
advantageous if it is necessary to remove fabrics after placement.
AMP-based electrospun constructs have been shown to be cytocompatible, have
pore sizes of fabric comparable to cellular dimensions, and provide an open-pore

152

structure that could be advantageous for wound healing applications. In addition, AMP
materials have varying hydrophilicity, which can be employed to modulate moisture at
the wound site. The low crystallinity and hydrophilic nature associated with these fabrics
could allow for better cellular compatibility and adhesion than their hydrophobic
counterparts.

As such, these fabrics merit further studies for use in wound healing

applications.

153

Literature Cited
1. Zhu Y, Chian KS, Chan-Park MB, Mhaisalkar PS, Ratner BD. Protein bonding on
biodegradable poly(L-lactide-co-caprolactone) membrane for esophageal tissue
engineering. Biomater 2006;27(1):68-78.
2. Jansen EJ, Sladek RE, Bahar H, Yaffe A, Gijbels MJ, Kuijer R, Bulstra SK,
Guldemond NA, Binderman I, Koole LH. Hydrophobicity as a design criterion for
polymer scaffolds in bone tissue engineering. Biomaterials 2005;26(21):4423-31.
3. Park GE, Pattison MA, Park K, Webster TJ. Accelerated chondrocyte functions on
NaOH-treated PLGA scaffolds. Biomater 2005 Jun;26(16):3075-82.
4. Miot S, Woodfield T, Daniels AU, Suetterlin R, Peterschmitt I, Heberer M, van
Blitterswijk CA, Riesle J, Martin I. Effects of scaffold composition and architecture on
human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. Biomater
2005;26(15):2479-89.
5. Oh SH, Kang SG, Kim ES, Cho SH, Lee JH. Fabrication and characterization of
hydrophilic poly(lactic-co-glycolic acid)/poly(vinyl alcohol) blend cell scaffolds by meltmolding particulate-leaching method. Biomater 2003;24(22):4011-21.
6. Kim SS, Ahn KM, Park MS, Lee JH, Choi CY, Kim BS. A poly(lactide-coglycolide)/hydroxyapatite composite scaffold with enhanced osteoconductivity. J Biomed
Mater Res A 2007;80(1):206-15.
7. Tessmar JK, Gopferich AM. Customized PEG-derived copolymers for tissueengineering applications. Macromol Biosci 2007;7(1):23-39.
8. Lindsey, III JM, Ingram D. Poly-Med, Inc. Internal Report No 141206. 2006.

154

9. Lindsey, III JM, Corbett JT, Carpenter KA, Greene DD, Anneaux BL, Shalaby SW. In
Vitro Mass Loss Profiles of Absorbable Sutures: Accelerated Protocols for Comparative
Evaluation. 7th World Biomaterials Conference. Trans Soc Biomat 2004;27:516.
10. Ovington LG. Hanging Wet-to-Dry Dressings Out to Dry. Adv Skin Wound Care
2002;15(2):79-86.
11. Baranoski S, Ayello EA. Wound Care Essentials: Practice Essentials. 2004.
Philidelphia (PA): Lippincott Williams & Wilkins. Pp 128-49.
12. Bryant RA. Acute and Chronic Wounds: Nursing Management. 2nd ed. 2000. St.
Louis (MO): Mosby. Pp 57,96.

155

CONCLUSIONS

Through the course of this research, several specific conclusions were made
pertaining to the development of electrospun fabrics for possible use in wound healing
devices. The most important of these conclusions include the following:
•

PAX-2 and PAX-6 were electrospun from solutions containing 15-25w/v%
polymer in mixtures of dichloromethane and chloroform

•

PAX-2 electrospun fabrics were radiation sterilized with up to 10kGy γirradiation with less than 10% change in molecular weight

•

Eluents from electrospun fabrics prepared from PAX-2 and PAX-6 were shown to
not be cytotoxic to L929 mouse fibroblasts using an agarose diffusion assay

•

By changing the DCM to CHCl3 ratio from 40/60 to 50/50 in solutions used to
form PAX-2/PVP electrospun fabrics, the percentage of PAX-2 on the fiber
surface increased from 28% to 68%

•

PMMA was electrospun containing a visually uniform dispersion of 55% BaSO4

•

Hydroxyapatite, phosphate glass, and PGA particles were uniformly dispersed in
PMMA and PAX-6 electrospun fibers from 3 to 11% loading

•

More than 90% of the proxyphylline was recovered after 2 hours of incubation in
37°C phosphate buffer, the highest recovery of any analyzed material

•

Radiation sterilization reduced the total proxyphylline release by nearly 50%

•

Electrospun PAX-6 containing 3% triclosan released less than 1% of the total
drug over a 28-day period at 37ºC in 7.2pH phosphate buffered solution
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•

PAX-6 fabric containing 2.5% triclosan was shown to inhibit the proliferation of
s. aureus, indicating antimicrobial efficacy, while PAX-6 fabric containing 0.2%
triclosan did not display inhibition due to drug release

•

Polymers containing 6.7% to 13.3% PEG in the main chain displayed varying
degrees of hydrophilicity (AMP-23, AMP-24, AMP-25, and AMP-26)

•

By increasing the PEG content from 6.7% to 13.3%, electrospun fabrics lost half
of their mass more than 6 times as quickly

•

As AMP-24 degraded, imaging showed electrospun fibers retained shape through
85% mass loss
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RECOMMENDATIONS

Introduction
In the process of completing this dissertation, more than one new direction to
further the research findings became evident. Low observed levels of material
degradation associated with electrospinning technology allows for the incorporation of
many biologically important materials into non-woven fibrous mats with fiber diameters
previously not possible. Additionally, the morphological features of electrospun
scaffolding can be on a cellular scale, which provides opportunity for improved tissue
engineering scaffolding or other cell-contacting devices like wound dressings.
Accordingly, the electrospinning technologies developed through this work may be used
as the basis for continued advancement.

Proposed Future Activities
7.1 Biocompatability Studies of Electrospun Substrates and Evaluation of Antimicrobial
Meshes

This collection of research has a common goal in that a proposed use of
electrospinning technology is for wound healing applications. To realize this specific
goal and create a final device with clinical applications, this and other research needs to
be continued and expanded upon. Before applying electrospun meshes in an animal
model, further understanding of cellular interactions is necessary. A full array of
biocompatability testing must be performed to ensure the safety of selected electrospun
fabrics. Cytotoxicity testing has been performed on PAX-2 fabrics, but will need to be
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performed on other PAX and AMP fabrics. This testing should be performed using an
agarose diffusion assay with eluents from incubated fabrics. Sensitization and irritation
tests must also be performed on the fabrics of interest.
Testing of meshes with an antibacterial component will determine the zone of
inhibition against staphylococcus aureus over a three week period. The bacteria can be
seeded on an agar surface, on which the antibacterial fabric is placed. The zone of
inhibition can thus be measured to determine the length of time and extent to which the
fabric provides antimicrobial properties.

7.2 Controlled Release of Bioactive Agents

The controlled release of drug from electrospun scaffolding may be one of the
more attractive features of the developed wound healing device. Previous work has
shown possible causes for changes in the release profiles of different drugs. Accordingly,
a system can be designed to release a controlled amount of drug over a predictable
amount of time. To be clinically effective, the drug must be relevant for a proposed
application. A drug of wound healing interest is triclosan, a commonly-used antibiotic.
The drug can be loaded in PAX and AMP fabrics in different amounts to release an
effective dose. An effective loading can be determined based on batch release data
(based on methods used previously) and zone of inhibition studies.
Additionally, the inclusion of a soluble drug in electrospun fibers made from
phase-separating materials (such as those prepared earlier), could further modulate the
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release of drug. As the polymers precipitate from the spinning solution and form coresheath fibers, the drug will tend to concentrate in either the core or sheath.
Additionally, because a major proposed application of electrospun fabrics include
use as wound dressing, it would be of interest to test select systems under clinicallyrelevant conditions. In a clinical setting, wound dressings are in contact with the body on
one surface and the other surface may be open to ambient conditions such as moving air
and temperature differentials. To perform this study, a novel test apparatus could be
constructed to mimic such conditions. This may create more relevant test conditions for
proposed wound dressings.

7.4 Study of Degradation of AMP- and PAX-based Electrospun Fabrics

Studies performed in Chapter 6 indicated the degradation of AMP-based
electrospun fabrics could possibly be a result of surface erosion instead of bulk
degradation, as typically seen in absorbable polymer systems. This could be due to the
small dimensions associated with electrospun fibers, causing no major difference
between the outer construct layers and the interior regions. One would postulate that the
hydrophilic nature of the AMP fabrics studied would result in bulk degradation, but this
was not clearly evident. As such, additional studies are warranted to determine the
method of degradation associated with AMP- and PAX-based electrospun fabrics.
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7.3 Animal Model and Protocol for Evaluating Device Safety and Efficacy

To study the efficacy of these newly developed medical devices in a controlled in
vivo setting, it will be necessary to employ an animal model to approximate the possible
response in human patients. Acute skin wounds in animal models can be created by
punch biopsy, surgical incision, tape tear, burn, or by dermatome. In the latter method,
the dermatome can be used to remove a precise amount of skin. Full-thickness wound
models offer significant wound volume and require the involvement of all dermal
components. Epithelialization occurs from the wound margins, which makes it easier to
track wound healing rates, histological orientation of connective tissue, and collagen
content.1 To isolate the dermis and the epidermis, a salt-split technique can be used to
prepare microscopy samples, but this cannot be used to examine the mechanism of
healing.2,3
Domestic pigs are commonly used because their skin has many properties similar
to humans, but also is variable in thickness, which can make tensile tests quite variable.
Rats and mice are also used for burn wound models, as well as the pads of guinea pig
feet. Small animal models can behave quite different than humans due to loose skin and
hair follicle differences, but porcine models show the most similarity to human skin.2
The porcine model is structurally similar in epidermal thickness, hair follicles, and blood
vessels, along with similar physical and molecular response to growth factors.
The method of wound preparation proposed for a study of healing with absorbable
electrospun fabrics includes using a dermatome to create several full-thickness skin
wounds in the thoracic area. As the model is designed to study wound healing, it will be
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important to prepare the area in a manner to isolate the effects of the healing devices, e.g.
no antiseptic or antibacterial soap prior to wounding. After wounding, electrospun
fabrics of interest would be applied to the wound site, along with a control dressing. Of
specific interest are fabrics prepared of PAX-2, PAX-2 with an antibacterial drug such as
Triclosan, and AMP-23.
Several methods are proposed to measure wound site response to the electrospun
fabrics. Wounds should be analyzed at 7, 14, and 21 days for several factors. The
wounds should be digitally imaged to analyze wound and periwound inflammation areas,
which would be plotted against healing time. Additionally, images of the wound should
be evaluated against a visual wound evaluation scale similar to the Hollander wound
evaluation scale. Wounds should be graded based on amount of hemmorage, wound
edges (presence of jagged edges or undermining of epidermis and wound color), and
discharge. At each time point, animals would be sacrificed to collect samples for
histological evaluation. Samples would first be prepared by separating the epidermis
from the dermis using a salt-split technique. Sections would be prepared and stained with
hematoxylin and eosin to determine general wound morphology and level of immune
response. Masson trichrome stain could also be used to visualize collagen and
differentiate between cellular and extracellular items.
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